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Abstract 
 
Hypothermia is defined as a core body temperature of 35°C or less and can be 
induced (i.e. therapeutic) or accidental. It is well established that hypothermia 
leads to a positive inotropic response which causes an increase in the magnitude 
of cardiac contraction, however rewarming from hypothermia is associated with 
a negative inotropic response, and the underlying mechanisms of this remain 
unclear. Accidental hypothermia is further complicated by risk of ventricular 
arrhythmias and cardiac arrest. This contributes to high mortality rates among 
these patients.  Although hypothermia is used extensively as a therapeutic 
intervention and survival is possible after extreme exposure, treatment of 
arrhythmias during rewarming is still challenging. In order to develop targeted 
anti-arrhythmic strategies in this very specific situation, we first need to 
understand the basis for pro-arrhythmia during cooling and rewarming. This 
study aimed to examine the effect of hypothermia and rewarming on aspects of 
cardiac inotropy and excitability. 
 
An in vitro model of hypothermia and rewarming using isolated rat ventricular 
cardiomyocytes showed that following 3 hours of hypothermia there was a 
significant reduction in shortening upon rewarming. This was not accompanied 
by a change in intracellular Ca2+, suggesting a rewarming induced decrease in 
myofilament sensitivity to Ca2+.  In separate experiments, animals underwent an 
in vivo hypothermia/rewarming procedure and displayed evidence of rewarming 
induced contractile dysfunction. Epicardial action potential (AP) measurements 
on these hearts showed a shortened AP duration (APD) when compared to 
normothermic control animals, which suggests that a sustained 
electrophysiological effect that could manifest as a shortened QT interval. In 
contrast to this, a period of transient hypothermia had alternative detrimental 
effects on the cardiac APD when compared to prolonged hypothermia, an effect 
that could predispose to the induction of long QT related arrhythmias and 
ventricular tachycardia. 
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Separate experiments assessed the effect of moderate (31˚C) and severe (17˚C) 
hypothermia on cardiac excitability in Langendorff perfused rabbit hearts.  
Moderate hypothermia prolonged PR and QT intervals whilst in severe 
hypothermia all ECG parameters were prolonged. Ventricular activation times 
were unaffected at 31°C whilst action potential duration (APD90) was 
significantly prolonged. At 17°C there were significant and proportionally similar 
delays in both activation and repolarisation. Ventricular fibrillation (VF) 
threshold was significantly reduced at 31°C (pro-arrhythmic), but at 17°C VF 
threshold was >2x baseline (37°C) (anti-arrhythmic). At 31°C, transverse 
conduction (CVt) was relatively insensitive to cooling versus longitudinal 
conduction (CVl) but at 17°C both CVt and CVl were proportionately reduced to a 
similar extent. The gap junction uncoupler heptanol had a larger relative effect 
on CVt than CVl, and at 31°C was able to restore the CVt/CVl ratio, returning VF 
threshold to baseline values. This suggests that moderate hypothermia creates 
repolarisation abnormalities and is pro-arrhythmic. These divergent effects 
appear to be linked to a lower temperature sensitivity of gap junctions, a 
conclusion supported by the anti-arrhythmic effect of heptanol at 31°C. 
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Normal thermoregulation involves a dynamic balance between heat production 
and control of heat loss, with the aim of providing a constant core temperature.  
In humans, body temperature is controlled by the thermoregulatory centre in 
the hypothalamus. It receives input from two sets of thermoreceptors; receptors 
in the hypothalamus itself monitor the temperature of the blood as it passes 
through the brain (core temperature), whilst receptors in the skin monitor the 
external temperature. The thermoregulatory centre sends impulses to several 
different effectors to adjust body temperature. In humans, a normal adult core 
temperature ranges from 36.5°C to 37.5°C and temperatures out with this 
narrow range are poorly tolerated (Connolly and Worthley, 2000).  
 
Hypothermia 
Hypothermia is defined as a core body temperature of 35°C or less and can be 
induced (i.e. therapeutic) or accidental. 
 
Stages of hypothermia 
Guidelines distinguishing the depth or stages of hypothermia have differed 
between authors, and as a result there are various definitions within the 
published literature.  It was initially suggested that hypothermia should be 
considered as either three stages; mild (35-32°C), moderate (32-22°C) and deep 
(22-8°C) (Popovic and Popovic, 1974) or four stages; mild (35-32°C), 
moderate(31-26°C), deep (25-20°C) and profound (19-14°C) (Wong, 1983). More 
recently it has been proposed that mild (35-32°C ), moderate (32-28°C) and 
severe (<28°C) are more appropriate classifications, and these are currently 
used by the European Resuscitation Council (Moss, 1986; Soar et al., 2010). In 
slight contrast, the American Heart Association has arbitrarily adopted the 
definition of Polderman et al which states mild hypothermia as temperatures 
down to 34°C, moderate 34-30°C and severe <30°C (Polderman and Herold, 
2009; Vanden Hoek et al., 2010). A single measurement of core temperature is 
often used to classify hypothermia as mild, moderate or severe. Frequently, the 
treatment of hypothermia patients depends on the severity level, therefore as 
our understanding of the pathophysiological mechanisms of hypothermia 
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improves it is important to have a general consensus on the stages so that 
treatment is appropriately targeted. 
 
Accidental hypothermia 
Accidental hypothermia is traditionally referred to as the unintentional lowering 
of body temperature to below 35°C. The causes of accidental hypothermia are 
multifactorial and can be sub-divided based on the circumstances surrounding 
the cooling. Acute hypothermia occurs when there is a sudden and severe 
exposure to a cold stress which is so great that the body’s intrinsic heat 
production is overwhelmed and the body cools before energy reserves are 
exhausted. In these circumstances the victim will rewarm once removed from 
the cold stress. This is most commonly seen following immersion in cold water, 
or being hypothermic whilst under the influence of alcohol in low ambient 
temperatures (Lloyd, 1979).  Second is subacute (exhaustion) hypothermia. In 
this situation the cold stress is less severe, and cooling only occurs when energy 
reserves are exhausted. Spontaneous rewarming is less certain in these 
circumstances and therefore every route of heat loss must be prevented. This 
type of hypothermia is most commonly found in climbers exposed to the 
elements (moderate cold and wind/rain), hikers, in endurance sport or people 
who have been immersed in warmer water. Third is chronic hypothermia, where 
a person has been exposed to a moderate cold stress for a prolonged period of 
time (days). This is typically found in the elderly, where core temperature 
decreases over time. Finally, there is submersion hypothermia, where 
hypothermia occurs as a result of full body immersion in cold water.  A number 
of reports have shown survival is possible in patients without oxygen for up to 60 
minutes following submersion (Lloyd, 1996; Avellanas et al., 2012). 
 
Physiological effects of hypothermia 
Hypothermia has profound systemic effects that involve many of the body’s vital 
organs. The initial effect of hypothermia involves a sympathetic response that 
causes vasoconstriction followed by shivering, an involuntary muscular activity 
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that enhances heat production in an attempt to restore homeostasis (Figure 
1.1). 
 
Figure 1.1 The process of thermoregulation.  
In humans, core temperature is normally maintained within a tight range (36.5–37.5°C) 
known as the thermo-neutral zone. When core temperature falls, thermoregulatory 
responses such as vasoconstriction and shivering are triggered. When temperatures rise 
above this range, vasodilation and sweating are typical homeostatic responses 
 
There are numerous physiological effects of hypothermia, some of the non-
cardiac ones are described in Table 1.1. Briefly, in mild hypothermia, patients 
may have vigorous shivering and cold white skin.  As temperatures drop to 
moderate hypothermia, there may be evidence of mental status changes such as 
amnesia, confusion and apathy in addition to reduced shivering, slurred speech 
and loss of fine motor skills. Most severely hypothermic patients have no 
shivering and present with hallucinations, fixed dilated pupils, bradycardia, 
hypotension and pulmonary oedema (Mallet, 2002).   
 
Cardiovascular 
Whilst the brain is protected from the effects of lack of oxygen during 
hypothermia, survival is dependent on other factors, namely having sufficient 
cardiac function to maintain adequate perfusion. In mild hypothermia there is an 
initial tachycardia and peripheral vasoconstriction alongside an increased 
myocardial oxygen consumption resulting in an increased cardiac output (CO). As 
temperature drops there is a progressive decrease in heart rate (HR) and CO. 
Experimental work in dogs has shown that at 25˚C, HR is reduced by almost 60% 
(Ohmura et al., 1979) alongside a 65% reduction in CO (Tveita et al., 1994).  
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Table 1.1: Physiological effects of hypothermia 
 Core 
Temp 
(°C) 
Respiratory Central Nervous 
System 
Neuromuscular 
Mild 35-32 Initial tachypnea 
then progressive 
decrease in 
respiratory 
function; 
bronchospasm 
Depression of cerebral 
metabolism; amnesia, 
impaired judgement; 
maladaptive behaviour 
 
Ataxia; shivering 
Moderate 32-28 Hypoventilation; 
loss of protective 
airway reflexes; 
50% decrease in 
O2 consumption 
Hallucinations; EEG 
abnormalities; 
paradoxical undressing  
 
Decreased 
reflexes; rigidity 
Severe <28 Pulmonary 
oedema; 75% 
decrease in O2 
consumption 
Decline in cerebral 
blood flow; global loss 
of reflexes; further 
decrease in EEG 
activity 
 
No motion; 
decreased nerve- 
conduction 
velocity; absent 
reflexes 
 
Adapted from (Danzl and Pozos, 1994; Petrone et al., 2014) 
 
The electrocardiographic (ECG) features of hypothermia can be nonspecific but 
can include prolongation of PR and QT intervals and can also include classic J 
(Osborn) waves in >50% of patients (Mustafa et al., 2005). The J wave, seen as 
an upward deflection at the junction of the QRS complex and the ST segment is 
not specific to hypothermia and can be found in a number of cardiac arrhythmia 
syndromes e.g. Brugada syndrome (Antzelevitch and Yan, 2015). Both atrial and 
ventricular arrhythmias can occur in hypothermia and asystole commonly occurs 
below 20 ˚C (Kempainen and Brunette, 2004). 
 
Epidemiology of accidental hypothermia 
Media reports of accidental hypothermia will typically focus on outdoor 
enthusiasts who have been exposed to cold, harsh conditions in remote settings.  
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However, there are in fact two main sub-divisions people with accidental 
hypothermia fall into:  
Firstly, those otherwise healthy individuals who suffer hypothermia due to 
exposure to extreme cold, wet or windy conditions often as a result of excessive 
exposure to snow, water or altitude. A 10 year review of accidental hypothermia 
in the French Alps found that of 48 patients admitted with severe hypothermia 
(16-28˚C), 56% were as a result of exposure to cold environment, 27% as a result 
of avalanche and the remaining 17% from immersion in cold water  (Debaty et 
al., 2015).  These circumstances are relatively uncommon, however the 
temperatures involved can be very severe.  The lowest recorded core 
temperature from which someone survived was as a result of exposure to 
extreme weather conditions. A skier survived with a good neurological outcome 
following 7 hours of circulatory arrest and a core temperature of 13.7˚C 
following an accident in Northern Norway (Gilbert et al., 2000).  
Secondly, and perhaps under-appreciated is the frequency with which 
hypothermia occurs in urban areas, particularly amongst the elderly, and those 
socially and economically challenged. The elderly are often immobile, either due 
to trauma or infirmity and often have a decreased muscle mass, which in 
combination with an age related decline in thermoregulatory capacity make 
them high risk candidates for hypothermia (Collins et al., 1977; Reuler, 1978).  
Two studies examining the incidence of accidental hypothermia in urban areas of 
Scotland found the average age of patients to be 69-76 years old (Ledingham and 
Mone, 1980; Rankin and Rae, 1984).   
Those who are socially deprived are also at risk from hypothermia, this could be 
as a result of inadequate/no housing, or substance abuse.  In Japan, 
hypothermia is the leading cause of death amongst the homeless irrespective of 
age (Suzuki et al., 2013).  Substance abuse, in particular alcohol is commonly 
reported alongside hypothermia. A study examining hypothermia as a cause of 
death in British Colombia found during a 14 year period that over 40% of patients 
were under the influence of alcohol when hypothermia occurred (Stares and 
Kosatsky, 2015). 
Contrary to what many believe, hypothermia does not only occur in cold 
countries. Whilst there is a much higher incidence in cold climates, hypothermia 
can also occur in more temperate regions. De Souza (2007) reported that in one 
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hospital in Sao Paulo, Brazil, 59 patients were admitted with hypothermia 
between 1988 and 2003, despite a tropical climate with mild annual average 
temperatures of 20-25°C. Similarly, between 2001 and 2005 there were 24 cases 
of fatal hypothermia in Sydney, Australia (Lim and Duflou, 2008), further 
highlighting the need for milder countries to be aware of the risk of 
hypothermia. 
 
Rewarming strategies 
It is a priority to stabilise and rewarm victims of accidental hypothermia. The 
method of rewarming will depend on the stage and circumstances surrounding 
the hypothermic patient and there are various methods available (Table 1.2). 
For patients with mild hypothermia, passive external warming is usually 
sufficient, however as hypothermia becomes more severe then active methods 
of rewarming become necessary. For patients with a core temperature <28˚C 
and cardiac arrest, the American Heart Association recommend extracorporeal 
warming (Vanden Hoek et al., 2010). Patients should therefore always be 
transported to the closest available centre based on their rewarming needs.  Of 
84 patients admitted to one hospital in the Netherlands, 14 different methods 
were used (van der Ploeg et al., 2010). This highlights the differing 
nature/circumstances surrounding accidental hypothermia and how each patient 
requires specialised treatment. 
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Table 1.2: Rewarming techniques for hypothermia  
 
(Adapted from: Gregory et al., 1991; Daanen and Van de Linde, 1992; Danzl and Pozos, 
1994) 
 
Mortality 
Whilst not a common cause of death, accidental hypothermia still accounts for 
significant mortality. It has been reported that hypothermia is involved in more 
than 1500 deaths annually in the United States (Brown et al., 2012), whilst 
official figures from death certificates in Scotland state hypothermia is 
responsible for approximately 40 per year. There is a lot of variation in reported 
death rates following accidental hypothermia, with mortality rates between 17 
and 69% (Ledingham and Mone, 1980; Farstad et al., 2001; Silfvast and Pettilä, 
2003; van der Ploeg et al., 2010; Debaty et al., 2015). A possible reason for such 
variation in the mortality rates is that it is an inhomogeneous population 
affected by hypothermia, severity and rewarming methods can vary, and it can 
be recorded as the primary or secondary (to an underlying condition) cause of 
death. 
 
 
 
Passive Removal from environmental exposure 
Dry patient 
Warm environment 
Blanket/clothing insulation 
Active external  External convection heaters 
Immersion in heated water bath 
Heating pads, warm water bottles 
Active internal Heated IV solutions 
Peritoneal lavage 
Warmed inhalational agents 
Extracorporeal  Cardiopulmonary bypass 
Haemodialysis  
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Therapeutic hypothermia 
In contrast to accidental hypothermia, therapeutic hypothermia is a clinician 
driven modality aimed at intentionally decreasing a patient’s core body 
temperature. The idea of using hypothermia therapeutically is not a new 
concept and has been around for centuries, however many abandoned the idea 
due to adverse effects (Alzaga et al., 2006). The current clinical application of 
therapeutic hypothermia stems in part from experimental observations of 
Bigelow and associates in the 1950s.  Their work demonstrated a potential 
beneficial effect of therapeutic hypothermia for the brain and heart during 
cardiac surgery in a canine and monkey model (Bigelow et al., 1950;  Bigelow 
and McBirnie, 1953). More recently, mild hypothermia (34°C) was shown to have 
beneficial neurological outcomes, without deleterious effects, if induced 
immediately post cardiac arrest in dogs. However, severe hypothermia (15°C) 
was shown to have the opposite effect, and could worsen cardiovascular and 
neurological outcome (Weinrauch et al., 1992).  
 
Experimental research into therapeutic hypothermia continued from these 
studies, however it was the findings from two prospective, randomised 
controlled clinical trials in 2002 that led to a shift in treatment 
recommendations. Both looked at the effect of mild – moderate hypothermia in 
patients with anoxic brain injury that had suffered cardiac arrest.  These trials, 
which were the largest to date, included several hundred patients and found a 
significant neurological protection in patients who were cooled to 32-34˚C 
(Bernard et al., 2002; Holzer et al., 2003). Based on these trials the American 
Heart Association and European Resuscitation Council recommended therapeutic 
hypothermia in such patients due to the favourable outcome. Recent meta 
analyses strongly support the neuroprotective effect of mild-moderate 
hypothermia (Arrich et al., 2016; Schenone et al., 2016). The beneficial effect 
of hypothermia as a neuro-protectant is the result of a reduction in tissue 
oxygen consumption and metabolic demand. The basal metabolic rate falls by 
~7-8%/˚C and so reaches 75-85% of normal in mild hypothermia and 65-75% of 
normal at moderate hypothermia (Reuler, 1978). 
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Therapeutic hypothermia is also used to varying degrees in other conditions such 
as aortic arch surgery. Cerebral protection has been the cornerstone of 
successful aortic arch surgery for almost 40 years and deep hypothermic 
circulatory arrest (DHCA), with temperatures as low as 15-20˚C has been a main 
strategy to achieve this (Di Luozzo and Griepp, 2012). Cooling the brain down to 
hypothermic temperatures is sufficient to reduce brain metabolic requirements 
to such an extent that blood flow can be completely interrupted. Most notably, 
DHCA offers surgeons a bloodless operating field and extended surgical time 
limit while meeting the body’s high metabolic demands. Whilst other perfusion 
techniques have been developed, many clinicians have favoured hypothermia as 
the preferred technique due to the relative ease at which it can be carried out. 
It provides cerebral protection whilst minimising problems with perfusion 
techniques.  Its use has been supported by follow up studies involving more than 
400 patients which yielded positive clinical results, with low rates of side effects 
(such as stroke and seizures) accompanied by a good cognitive function  (Gega et 
al., 2007; Percy et al., 2009). 
 
Despite positive findings, it has also emerged that timing of DHCA is important, 
with longer periods of hypothermia showing evidence of temporary neurologic 
dysfunction (Tang et al., 2013).  Indeed, direct measurement of the Q10 
temperature coefficient for the cerebral metabolic rate in human beings showed 
that the safe limit of DHCA at 15˚C was only 30 minutes and that it was only 20 
minutes at 20˚C. The investigators in this study showed that maintaining a 
patient at 18˚C for longer than 25 mins decreased memory and fine motor 
function and prolonged hospital stays (McCullough et al., 1999).  Evidence would 
suggest that DHCA is therefore beneficial if it is performed within its safe limits 
however for more prolonged surgeries DHCA should be used in conjunction with 
other operative procedures. 
 
In recent years there has been growing interest into the beneficial effects of 
therapeutic hypothermia following ischaemic stroke. The protective mechanisms 
of hypothermia affect the ischaemic cascade across several parallel pathways 
and it is therefore a condition where cooling may increase positive outcomes.  
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Animal studies have reported favourable results  in both focal and global 
ischaemia (van der Worp et al., 2007; van der Worp et al., 2010). However, the 
impact on patients with ischaemic stroke has still to be fully explored.  Its 
transition to human trials presents many challenges, including time of initiation 
relative to stroke onset, and also depth and duration of hypothermia (Zhang et 
al., 2013). Recently a large scale trial looked to replicate the beneficial findings 
reported in small pilot studies.  Only 120 patients of the proposed 1600 were 
enrolled before the trial was stopped. Despite them reporting beneficial 
outcomes in the small sample size, mortality rates in the hypothermic group 
were double that in the control group (15.9% vs 8.8%) with pneumonia being a 
major cause of death (Lyden et al., 2016). Therefore, evidence suggests that the 
use of therapeutic hypothermia in stroke remains debatable and more work is 
required to bridge the knowledge gap between experimental and human trials 
(Tahir and Pabaney, 2016).  
 
Traumatic brain injury represents a significant challenge to healthcare, and is a 
leading cause of death and permanent disability (Maas et al., 2008). Therapeutic 
hypothermia has been well established as a treatment in this scenario for over 
40 years (Fox et al., 2010; Sadaka and Veremakis, 2012). It is based on the 
principle that cooling controls dangerously high intra-cranial pressure and 
mediates damage to neural tissue from hypoxic and metabolic mechanisms.  
However in recent years there has been growing evidence that therapeutic 
hypothermia is associated with unfavourable long term outcomes when applied 
clinically (Crossley et al., 2014; Honeybul, 2016).  This has been shown in both 
meta-analysis of previous studies (Shaefi et al., 2016) and also in recent large 
scale clinical trials (Andrews et al., 2015), which was stopped early when it was 
shown that hypothermia did not improve clinical outcome.   
 
Whilst in vivo studies have found favourable effects of therapeutic hypothermia, 
they have often not translated to clinical work. This highlights the important 
point that ultimately the full effectiveness of cooling cannot be completely 
understood until there are more robust, randomised clinical trials with large 
volumes of patients. 
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Temperature and cell activity  
Thermoregulation is the fine balance between heat production and heat 
elimination. This active equilibrium, which maintains the body’s core 
temperature at ~37C allows the cellular enzyme systems to function within a 
narrow optimum metabolic window. Changes in temperature which affect 
physiological processes and can be quantified by Q10 (temperature coefficient), 
which describes the amount by which the processes change in response to a 10˚C 
increase in temperature (the more temperature dependent a process is; the 
higher the Q10 value).  
 
The cardiac excitation and contractile processes are markedly influenced by 
changes in temperature (Langer and Brady, 1968). Under normal circumstances 
the activity of channels, pumps and exchangers are tuned to 37˚C but when 
temperature decreases, so too does the relative activity. However this change is 
not uniform,; gating kinetics (i.e. where the conformation of a channel changes 
through activation or inactivation) and exchangers (e.g. Na+/Ca2+ exchanger, 
(Puglisi et al., 1996)) can have a range of Q10 values, with some aspects more 
temperature dependent than others. There is also evidence of temperature-
dependent slowing of the kinetics of a number of pumps and ionic currents (ICa, 
INa, IK) (McDonald and Trautwein, 1978; Eisner and Lederer, 1980; Colatsky, 
1980; Cavalié et al., 1985; Kiyosue et al., 1993; Puglisi et al., 1996).  Due to the 
complex processes involved, both Ca2+ handling mechanisms (Shattock and Bers, 
1987) and myofilament Ca2+ sensitivity contractile properties (Harrison and Bers, 
1989; Kusuoka et al., 1991; Stehle et al., 2002) are therefore highly temperature 
dependent. 
 
Excitation Contraction Coupling 
Excitation contraction (E-C) coupling involves the cellular processes from the 
electrical signal through to the mechanical contractile response. Following the 
electrical excitation from the action potential (AP), the sarcolemma including 
the transverse tubules (t-tubules) are depolarised resulting in the activation of 
the voltage sensitive L-type Ca2+channels (LTCC). These LTCC are located 
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primarily at the junction of the sarcolemma and sarcoplasmic reticulum (SR), 
the internal cardiomyocyte Ca2+ store. This inward Ca2+ current activates the 
nearby ryanodine receptors (RyRs) to release Ca2+ from the SR, in a process 
known as Ca2+ induced Ca2+ release (CICR). This graded increase in free 
intracellular Ca2+ ([Ca2+]) allows for more binding of Ca2+ to troponin C, which 
initiates contraction of the myofilaments through the conformational change 
that occurs in the actin-myosin complex leading to cross bridge formation. When 
this occurs in a co-ordinated fashion, the concurrent increase in Ca2+ leads to 
contraction of the whole cell, and when it occurs across the myocardium is the 
basis for systole (Calaghan and White, 1999; Bers, 2002). 
 
During the relaxation phase, intracellular levels of Ca2+ must decline, allowing 
the dissociation of Ca2+ from troponin C, thus ensuring relaxation of the 
myocardium and consequent filling of the heart. The main process by which Ca2+ 
is re-sequestered within the cell is by the SR through the SR Ca2+ ATPase 
(SERCA), which in exchange for adenosine tri-phosphate (ATP) is able to uptake 
Ca2+ from the cytosol. Whilst SERCA is the predominant mechanism by which Ca2+ 
is removed from the cytosol (~70%), other mechanisms also contribute; the Na+-
Ca2+ exchange (NCX) (~28%), where high cytoplasmic Ca2+ initiates an outward 
Ca2+ and an inward Na+ flux, whilst the plasma membrane Ca2+ ATPase (PMCA) 
and the mitochondrial Ca2+ uniporter account for ~1% each (D. M. Bers, 2002). 
 
Cooling has been shown to have multiple effects on EC-coupling mechanisms, 
including but not limited to; increasing AP duration (APD) (Shattock and Bers, 
1987), slowing rate of NCX (Puglisi et al., 1996); reducing the magnitude of the 
L-type Ca2+ current (Cavalié et al., 1985), and increasing the open probability of 
SR Ca2+ release channels (Sitsapesan et al., 1991).  
 
PKA signalling 
The heart provides an example of how two signalling pathways that are involved 
in elevating the levels of two intracellular second messengers, cyclic AMP (cAMP) 
and Ca2+, can interact physiologically. As described, in response to 
depolarisation, Ca2+ enters the cytoplasm and triggers Ca2+ induced Ca2+ release. 
This influx of Ca2+ triggers the release of intracellular stores of Ca2+ from the SR, 
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and the ensuing intracellular Ca2+ transient results in activation of the 
myofilaments. 
 
Beta-adrenergic stimulation has a positive inotropic effect on the Ca2+ handling 
in cardiac myocytes by activating adenylyl cyclase to produce cyclic-adenosine 
monophosphate (cAMP), which activates PKA. This kinase phosphorylates several 
proteins related to EC-coupling, including L-type Ca2+ channels, RyR and troponin 
I ( Bers, 2002). On phosphorylation of the LTCC by PKA, ICa is increased (Bers, 
2001; Reuter, 1987) increasing cytosolic Ca2+, SR Ca2+ content and thereby 
increasing the amplitude of the Ca2+ transient (Bers, 2002).  
 
The ryanodine receptor (RyR2) is also a target of PKA - this increases RyR2 
sensitivity to Ca2+ (Bers, 2001) and further facilitates CICR and therefore 
increases cytosolic [Ca2+] (Bers, 2002). This increase in systolic Ca2+ is largely 
responsible for the positive inotropic response to β-AR stimulation. SERCA2 is 
also a target for PKA phosphorylation following β-AR stimulation. Phospholamban 
(PLB) - an inhibitory protein which inhibits SERCA2 in the unphosphorylated state 
- relieves inhibition of SERCA2 when phosphorylated by PKA. This increases 
reuptake of Ca2+ from the cytoplasm and generates the positive lusitropy caused 
by β-AR stimulation. It also contributes to positive inotropy - a combination of 
increased systolic Ca2+ and increased uptake by SERCA2 increases the SR Ca2+ 
content (Bers, 2002).  
 
cTnI is a key regulatory protein in cardiac muscle contraction and relaxation, 
and phosphorylation by PKA results in a decrease in the sensitivity of the 
contractile apparatus to Ca2+. After phosphorylation the half-maximal ATPase 
activity and half-maximal tension are achieved at higher Ca2+ concentrations, an 
effect that may be due to decreased affinity of troponin I to troponin C (Filatov 
et al., 1999). Indeed the phosphorylation at specific sites (Ser23/24) on cTnI has 
been shown to be mechanistically involved in reduced myofilament sensitivity in 
various pathological situations (Gao et al., 1995; Tavernier et al., 2001; Chen 
and Ogut, 2006). 
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Inotropic dysfunction 
When normal EC coupling is disrupted it can cause a cascade of inotropic defects 
leading to reduced force production and a weakened contraction. An example 
situation where this occurs is in the disruption of normal cardiac metabolism 
e.g. following hypoxia or ischaemia (Allen and Orchard, 1987). 
 
The metabolic demands of the heart are the highest of any organ in the body, 
and normal cardiac metabolism is required to fuel contractile function and 
viability. More than 95% of adenosine triphosphate (ATP), the immediate energy 
source, is generated by oxidative phosphorylation in the mitochondria. This ATP 
re-phosphorylates creatine to generate creatine phosphate (PCr), which then 
shuttles the metabolic energy to the sites of energy consumption (primarily the 
contractile proteins) where PCr is used to phosphorylate local adenosine 
diphosphate (ADP) via creatine phosphokinase. If aerobic metabolism is 
prevented, e.g. by hypoxia or malfunctioning mitochondria then ATP can be 
supplied anaerobically for a limited period of time. However, this switch from 
aerobic to anaerobic metabolism has subsequent consequences for the heart; a 
rapid fall in PCr levels (due to a mismatch in supply and consumption) and also a 
corresponding increase in inorganic phosphate (Pi) (Allen et al., 1985; Kusuoka 
et al., 1986) and production of lactic acid (Elliott et al., 1992), leading to an 
intracellular acidosis. 
 
It has been known for some time that metabolic dysfunctions can lead to 
contractile dysfunction (Cingolani et al., 1970; Fabiato and Fabiato, 1978;  
Poole-Wilson and Langer, 1979; Eisner et al., 1987; Jeffrey et al., 1987). This 
effect has been linked to an impairment in Ca2+ release from the SR as well as 
blockade of Ca2+ channels in the sarcolemma (Fabiato and Fabiato, 1978;  Poole-
Wilson and Langer, 1979) although there is also evidence to support a 
myofilament Ca2+  sensitivity (Marban and Kusuoka, 1987; Orchard et al., 1991).  
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Arrhythmias  
Under normal circumstances, electrical conduction of the heart involves a 
propagating AP which will stimulate the atria and ventricle in a co-ordinated 
manner, continuing until refractory tissue is encountered (Weiss et al., 2010). 
However, abnormalities in electrical activity can lead to disrupted impulse 
propagation. Cardiac arrhythmias are clinically of high importance, as the 
compromised mechanical activation can leading to circulatory impairment and 
potentially to sudden cardiac death (Chugh et al., 2008). 
 
Cardiac arrhythmias are generally produced by one of three mechanisms; 
i. Automaticity; enhanced automaticity can increase the rate at which an AP 
will be generated. 
 
ii. Triggered activity; resulting from premature activation of cardiac tissue 
either due to early afterdepolarisations (EADs), which correspond to phase 
2 and 3 of the AP and are usually associated with a prolonged APD; or 
delayed afterdepolarisations (DADs) which occur in phase 4 when the 
membrane potential has returned to baseline. 
 
iii. Re-entry; where an AP doesn’t terminate and re-excites regions that have 
recently repolarised (Antzelevitch et al., 2003) . 
 
Arrhythmias are generally considered to have separate trigger and 
arrhythmogenic substrate entities (Coumel, 1993). Triggers can be EADs or DADs, 
which can lead to ectopic beats, whilst the substrate refers to some abnormality 
which predisposes to re-entry, e.g. increased dispersion of conduction or 
repolarisation or scar/fibrosed tissue (Antzelevitch and Burashnikov, 2011). 
 
Clinically, long QT syndrome is a common finding in therapeutic hypothermia 
(Mattu et al., 2002; Khan et al., 2010; Kim et al., 2014; Salinas et al., 2015). The 
prolongation in APD associated with long QT syndrome may be a pro-arrhythmic 
substrate which can increase the propensity for afterdepolarisations (trigger). 
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Both polymorphic ventricular tachycardia or fibrillation and Torsades de pointes 
may develop in this setting, and are known complications of long QT syndrome 
(Weiss et al., 2010).  Recent studies have shown that in temperatures associated 
with therapeutic hypothermia there are numerous electrophysiological changes 
to the heart including; enhanced dispersion of repolarisation (Piktel et al., 2011; 
Hsieh et al., 2009; Salama et al., 1998), slowing of conduction (Fedorov et al., 
2008) and APD alternans (Hsieh et al., 2009).  The enhanced heterogeneity of 
repolarisation that has been shown in hypothermia is associated with increased 
incidence of arrhythmias and re-entrant excitation. With the widespread use of 
therapeutic hypothermia, it is important to have a thorough understanding of 
the electrophysiological effects so that appropriate treatment can be given to 
patients. 
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Aims 
The main aim of this thesis was to study the effect of hypothermia and 
rewarming on cardiac electrophysiology and mechanical function.  Hypothermia 
affects many aspects of cardiac function. Using temperatures that commonly 
occur in both therapeutic and accidental hypothermia, this thesis aimed to 
examine two main areas; 
1.) Inotropy 
2.) Excitability 
 
The specific aims of this work were: 
 
i. To study the characteristics of electrophysiology and mechanical function 
in isolated Langendorff perfused hearts following in vivo hypothermia and 
rewarming.  
 
ii. To investigate whether transient hypothermia affects cardiac 
electrophysiology by the same mechanisms as long term cooling. 
 
iii. To study an in vitro model of hypothermia and assess contractile response 
to hypothermia and rewarming in isolated cardiomyocytes 
 
iv. To assess temperatures and mechanisms that may lead to hypothermia 
induced arrhythmias. 
 
v. To study whether pharmacological gap junction uncoupling can alter 
conduction and VF threshold during moderate hypothermia. 
 
 
Karen McGlynn, 2017  Chapter 2 
35 
 
 
Chapter 2: General Methods 
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Animals  
Animals used at the University of Glasgow (Chapters 4, 5 and 6) were killed in 
accordance with Home Office Guidelines of the Animals (Scientific Procedures) 
Act 1986. 
Animals used at the University of Tromsø (Chapter 3) were killed in accordance 
with the Norwegian Animal Research Authority guidelines and experimental 
protocols were conducted according to the European Convention for the 
Protection of Vertebrate Animals used for Experimental and Other Scientific 
Purposes (Strasbourg, 18.III.1986). 
 
Physiological extracellular solutions 
All experiments performed on isolated cardiomyocytes used a modified Krebs 
solution.  For whole heart (rat and rabbit) experiments, a modified Tyrode's 
solution was used.  All chemicals were obtained from Sigma-Aldrich (Saint Louis; 
MO, USA) unless otherwise stated. 
 
Modified Krebs solution 
120 NaCl, 20 HEPES, 5.4 KCl, 0.52 NaH2 PO4, 3.5 MgCl26H2O, 20 taurine, 10 
creatine and 11.1 glucose (all concentrations in mM).  Solution pH adjusted to 
7.4 at 37 ˚C using NaOH.  
 
Modified Tyrodes solution 
93 NaCl, 20 NaHCO3, 1 Na2HPO4 (anhydrous),1 MgSO47H2O, 5 KCl, 25 Glucose, 20 
C2H9NaO5, 1.8 CaCl2 (all concentrations in mM).  Solution continuously bubbled 
with 95% O2/5% CO2 to maintain pH 7.4. Before being used all Tyrode's solution 
was filtered through a 5µm filter membrane (Millipore; Billerica, MA, USA). 
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Kraft-Bruhe (KB) solution 
70 KOH, 40 KCl, 50 L-glutamic acid, 20 taurine, 20 KH2PO4, 3 MgCl26H2O, 10 
glucose, 10 HEPES, 0.5 EGTA, pH 7.2 with KOH 
 
Langendorff perfused whole heart configuration  
Rabbit 
Male New Zealand White rabbits (2.5-3kg) were euthanised with an intravenous 
(I.V) injection of 0.5ml/kg Na pentobarbital (200 mg/ml, Euthatal) mixed with 
500IU of heparin via the left marginal ear vein.  Hearts were quickly excised 
once absence of pain reflexes were confirmed, and placed in ice cold Tyrode’s 
solution.  Excess tissue was trimmed away and the heart was connected to a 
Langendorff perfusion system (Figure 2.1) and perfused with oxygenated 
Tyrode’s (37°C) at a constant flow rate of 30ml/min (Skrzypiec-Spring et al., 
2007; Bell et al., 2011). The retrograde flow closes the aortic valve and as a 
result the perfusion solution is displaced via the ostia into the coronary arteries.  
To ensure adequate perfusion of the coronary vessels, pressure was measured 
throughout all experiments using a calibrated pressure monitor (Pressure Monitor 
BP1, World Precision Instruments; Sarasota, FL, USA).  The system was primed 
with Tyrode’s solution prior to starting to ensure no bubbles were present which 
could compromise the coronary vessels.   
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Figure 2.1 Schematic of Langendorff perfusion set up.  
 
 
Rat  
The preparation for the rat Langendorff was similar to the rabbit.  Male Wistar 
rats (250g-300g) were stunned with a blow to the head followed by a cervical 
dislocation, causing both ascending and descending injury to the spinal cord and 
brain stem.  The xiphoid process was identified and the thoracic cavity was 
opened to allow the rapid removal of the heart which was subsequently placed 
in ice cold perfusion buffer (Krebs/Tyrode’s) containing 25IU/ml heparin for 
anti-coagulation.  Excess tissue was trimmed and hearts mounted and tied via 
the aorta on to the cannula of a Langendorff perfusion system.  Hearts were 
perfused at 12ml/min until blood cleared from the coronary vessels and the 
perfusate ran clear. 
 
Cooling/rewarming protocol 
Hypothermia and rewarming was carried out on isolated cardiomyocytes, 
Langendorff perfused rat and rabbit hearts and also in vivo.  Due to the 
differences in optimal conditions between each of the experimental procedures, 
several cooling/rewarming protocols were carried out.  Each chapter describes 
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the methods particular for that study.  The temperatures used covered all 
aspects of hypothermia, from mild to severe. This wide spectrum allowed the 
study of temperatures routinely employed clinically and also those observed in 
victims of accidental hypothermia where core temperatures below 17°C are 
reported in patients with a positive neurological outcome after rewarming 
(Gilbert et al., 2000).  All cooling was achieved gradually in order to mimic 
gradual whole body cooling and avoid rapid cooling contracture (Rebeyka et al., 
1990, Lahorra et al., 1997). Every effort was made to keep cooling/rewarming 
time consistent within studies. 
 
Dyes 
Voltage sensitive dye 
Voltage sensitive dyes are fluorescent compounds which have a high affinity for 
the plasma membrane of cells and change their spectral properties in response 
to changes in transmembrane potential (Loew, 2011). They are classified as fast 
and slow response dyes and the aminonaphthylethenylpyridinium (ANEP) family 
of dyes are among the most commonly used due to their recording of voltage 
changes in the order of microseconds.  They have been well established in 
measuring electrical activity in whole heart preparations (Choi and Salama, 
2000; Efimov et al., 2004; Novakova et al., 2008). In particular, di-4-ANEPPs and 
di-8-ANEPPS are often utilised to accurately represent changes in membrane 
potential via changes in dye fluorescence (Morad and Salama, 1979). Both dyes 
yield a uniform 10% change in fluorescence per 100mV change in membrane 
potential but di-4-ANEPPS rapidly internalizes in cells, thus making it useful only 
for short-term experiments (Herron et al., 2012). 
Di-4 ANEPPs delivery to whole heart preparations is generally through bolus 
injection into the coronary arteries via the perfusion system.  The dye molecules 
intercalate into the extracellular side of the cell membrane due to affinity 
between the pair of hydrocarbons on the dye molecule and the amphiphilic lipid 
molecules in the membrane surface (Loew, 2011). The part of the molecule that 
gives it colour, also known as the chromophore, orientates perpendicular to the 
membrane surface.  During excitation, the dye molecules undergo a charge re-
distribution which causes a shift in the emission spectrum when a membrane 
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potential change occurs.  As shown in Figure 2.2, upon membrane 
depolarisation, there is a spectral shift to shorter wavelengths. 
 
 
Figure 2.2: Excitation and emission spectra of di-4 ANEPPS 
A: During rapid upstroke of the action potential, a depolarisation of the cell from its resting 
transmembrane potential (Vm) of = -80mV toward less negative voltage, e.g. Vm = -40mV and 
0mV, causes the fluorescence emission spectrum of the dye to shift to the left (shorter 
wavelengths), producing an inverted action potential signal.B: shows example traces of 
emission at both wavelengths. 
 
The specific loading of di-4-ANEPPS is described in more detail in Chapters 3 and 
5, however preparation of the dye was the same in all experiments.  The dye 
was made up of 1mg/ml stock solution in dimethyl sulphoxide (DMSO).  Stock 
solution was stored in darkness at room temperature. 
 
A 
B 
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Ca2+ sensitive dye  
The central concept underlying the use of Ca2+ indicators is that an acute 
increase or decrease in their fluorescence intensity reflects a change in 
intracellular Ca2+ concentration.  Ca2+ sensitive fluorescent indicators can be 
broadly divided into ratiometric (dual wavelength) or single wavelength 
indicators based on their response to Ca2+ elevation.   
 
Single wavelength indicators  display a change in their fluorescence emission 
when Ca2+ signals occur.  In contrast to this, ratiometric indicators when bound 
to Ca2+ change the optimum excitation or emission wavelength of the indicator 
(Grynkiewicz et al., 1985). For example, Fura-2, a ratiometric indicator, in the 
unbound form has a peak excitation wavelength of ~380nm, whereas the peak 
excitation wavelength when Ca2+ bound is ~340nm (Figure 2.3). Ratiometric 
indicators are among the most popular due to their higher robustness compared 
with single wavelength counterparts. A major advantage being that Ca2+ 
estimated with ratiometric compounds is not affected by uneven dye loading, 
photo-bleaching, optical path length or illumination intensity (Wokosin et al., 
2004).  Therefore, using ratiometry avoids many of the problems related to 
absolute fluorescence values.  
 
Fura-2 has a limited sensitivity to Ca2+ concentrations above 1µM, however other 
Fura derivatives with a lower Ca2+ binding affinity are available, including Fura 
4F-AM which has a response range shifted to detect higher Ca2+ concentrations.  
This acetoxymethyl (AM) ester derivative is useful for non-invasive intracellular 
loading.  Modification of carboxylic acids with AM ester groups results in an 
unchanged molecule that can permeate cell membranes.  Once inside the cell, 
the lipophilic blocking groups are cleaved by nonspecific esterases, resulting in a 
charged form that leaks out of cells far more slowly than its parent compound 
(Grynkiewicz et al., 1985).  
Karen McGlynn, 2017  Chapter 2 
42 
 
 
Figure 2.3: Excitation and emission spectra of Fura. 
 
Most experiments using calcium sensitive dyes such as Fura are carried out at a 
constant temperature (e.g. 37C). However, performing experiments at un-
physiological temperatures results in cellular responses that would not be 
observed under physiological conditions. Therefore, if temperature is being 
varied, the change on the fluorescent probe must also be considered during data 
interpretation.  One important consideration is a variation in the binding 
characteristics of the chelator.  Various studies have documented that for dyes 
such as Indo, Fura and fluo-3 that the binding equilibra are shifted at lower 
temperatures, therefore leading to an increased dissociation constant (Kd) and 
thus a lower affinity (Shuttleworth and Thompson, 1991; Howarth et al., 1995; 
Larsson et al., 1999).  Fortunately this type of error is easily avoided using the 
appropriate temperature corrected Kd for a given dye (Shuttleworth and 
Thompson, 1991). Another important consideration when temperature is 
changed during the course of an experiment is that the fluorescence itself is 
affected by temperature, regardless of binding characteristics.  As temperature 
increases, fluorescence intensity decreases. Likewise when temperature is 
cooled the fluorescence intensity increases, due to increases in quantum yield 
(Haynes et al., 1993).   
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These two effects of temperature on calcium sensitive dyes (i.e on binding 
characteristics and on fluorescence) are important when measuring free calcium 
concentrations.  It is possible to avoid the problem of the Kd effects by using the 
ratio of the wavelengths fluorescence intensities for the calcium bound to 
calcium free flurophores.  However this method does not control for the effects 
of temperature on the fluorescence intensity at those two wavelengths (Larsson 
et al., 1999).  
 
Preparation involved adding DMSO to 25mg Fura 4F-AM (Life technologies, 
Thermo Fisher Scientific; Waltham, MA USA).  Throughout different experiments, 
Fura 4F-AM was used at various concentrations and loading times differed.  As 
such, the experiment-specific use of Fura 4F-AM is described in detail in the 
relevant chapters (3 and 4). 
 
Excitation-contraction (E-C) uncoupling with blebbistatin 
E-C uncouplers are commonly used in cardiac optical mapping/conduction 
experiments for suppression of motion.  The basis of these compounds is to 
suppress muscle contraction whilst having little to no adverse effects on the 
electrical activity of the heart.  Several compounds are available including 
cytochalasin D (Cyto D), 2, 3- butanedione monoxime (BDM) and more recently 
blebbistatin.    
 
Blebbistatin is an inhibitor of the adenosine triphosphatases (ATPases) associated 
with class II myosin isoforms in an actin-detached state (Kovacs et al., 2004, 
Fedorov et al., 2007, Allingham et al., 2005). Its behaviour in this non-bound 
state is advantageous because it prevents any stiffness which may result from a 
constant actin-myosin crosslink.  Blebbistatin has been shown to have minimal 
effects on ECG parameters and atrial and ventricular electrophysiology 
compared with other E-C uncouplers (e.g.BDM) (Lou et al., 2012), and it has also 
been characterised in various experimental preparations in different species, 
including rat and rabbit (Farman et al., 2008; Fedorov et al., 2007).  
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A main disadvantage of blebbistatin is photosensitivity and phototoxicity.  
Studies have shown that both UV and blue light photo–inactivate blebbistatin, 
resulting in toxicity from the production of free radicals causing damage to the 
surrounding cells (Sakamoto et al., 2005; Kolega, 2004). Additionally, a recent 
study suggests that blebbistatin may have adverse effects in whole heart rabbit 
experiments, including APD prolongation and reduced VF threshold (Brack et al., 
2013). Therefore, it is important to consider these effects when evaluating 
experimental results. 
 
Preparation involved adding 1ml of DMSO to 5mg blebbistatin (Enzo Life 
Sciences).  Blebbistatin was used at both 3µM (Chapter 4) and 10µM (Chapters 5 
and 6). Prior to adding the blebbistatin, the solution was heated, allowing it to 
fully dissolve in the solution and minimise the chances of any precipitate forming 
in the coronary vessels (Swift et al., 2012).   
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Chapter 3: Cardiac electrophysiology following 
in vivo hypothermia and rewarming 
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Introduction 
Rewarming from hypothermia is associated with significant mortality and despite 
advances in medical therapy, has been associated with physiological effects 
including hypotension, reduced CO and diminished ventricular work (Prec et al., 
1949; Bigelow et al., 1950; Berne, 1954; Blair et al., 1956). Data generated from 
a rat model of hypothermia/rewarming has shown that upon rewarming from 
sustained severe hypothermia there is ~50% reduction in CO when compared to 
starting values (Tveita et al., 1996; Kondratiev et al., 2006a; Kondratiev et al., 
2006b).  HR and mean arterial pressure (MAP) were maintained as was oxygen 
supply and the relative oxygenation of cardiac tissue but this was alongside a 
substantially reduced CO.  Reducing temperature has a marked influence on 
many components of EC-coupling, and whether the dysfunction we see on 
rewarming is a consequence of the cooling, or from the increasing temperatures 
remains unclear.   
 
Hypothermia is known to have effects on ventricular repolarisation, and has 
been associated with a prolonged APD, resulting in a prolongation of the QT 
interval (Yan and Antzelevitch, 1996; Mattu et al., 2002). Multiple ionic currents 
which control repolarisation are particularly susceptible to hypothermia (Liu et 
al., 1991; Sprung et al., 1995; Marshall et al., 2002). Despite numerous studies 
examining cooling and rewarming  (Egorov et al., 2012; Fedorov et al., 2008; 
Hsieh et al., 2009; Piktel et al., 2011) to date, there has been no assessment of 
electrical function using the rat model of rewarming shock.  
 
Aims 
The main aims of this chapter were: 
Part 1: 
to assess cardiac electrophysiology and mechanical function in isolated perfused 
rat hearts following in vivo hypothermia and rewarming 
Part 2: 
to assess cardiac electrophysiology in isolated perfused rat hearts during 
transient hypothermia and rewarming  
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Part 1: The electrophysiological effects of hypothermia and 
rewarming in vivo 
 
Methods 
Animals 
Male Wistar rats (250-300g) were used for all experimental work in this chapter.  
All of the surgery was carried out within the Anaesthesia and Critical Care 
Research Group, Institute of Clinical Medicine, University of Tromsø, Norway. 
 
In vivo hypothermia and rewarming procedure 
Animals were assigned to either a normothermic (n=9) or hypothermic (n=9) in 
vivo procedure. The surgery took 60-90 minutes on average, and all animals, 
irrespective of group received the same surgical procedure.    
 
Anaesthesia and respiratory support 
Animals were given an initial intraperitoneal injection containing sodium (Na) 
pentobarbital (50mg/kg) and fentanyl (50µg/kg) which was then followed by a 
continuous infusion (7.5mg/kg/hr) via an intravenous (I.V.) line inserted in the 
right jugular vein. Animals in the normothermic control group received 
anaesthesia throughout the duration of the experiment whilst animals in the 
hypothermic group had the infusion terminated at 30°C due to reduced drug 
metabolism in hypothermia (Zhou and Poloyac, 2011; Wood and Thoresen, 2015). 
Infusion of anaesthesia was resumed at 30°C during rewarming.  Throughout all 
procedures animals were observed for any sign of discomfort by monitoring 
haemodynamics and also by toe-pinch, a recognised testing method for rodents 
under anaesthesia (Collier et al., 1961). 
At temperatures >20°C animals have spontaneous and sufficient ventilation, 
however at core temperatures <20°C ventilation had to be supported.  The 
trachea was opened and a tracheal tube inserted at the start of the procedure.  
When the animal was no longer able to support its own ventilation this tracheal 
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tube was then attached to a volume controlled small animal respirator (New 
England rodent ventilator, model 414, New England Instruments, Medway, MA) 
using room air.   
 
Ventilation was adjusted in accordance to blood gas analysis.  Samples (0.15ml) 
were drawn from the left femoral artery and analysed using a commercially 
available blood gas analyser (ABL 800 blood gas analyser, Radiometer, DK).  
These samples were analysed at 37°C using the alpha-stat strategy which does 
not require correction for pH and blood gas values in hypothermic conditions 
(Ashwood et al., 1983). 
   
Core cooling and rewarming 
Animals in the hypothermic group were cooled by circulating cold water through 
a U-shaped polyethylene tube which was placed in the lower bowels.  To further 
assist in cooling, the operating table was constructed of hollow double layered 
aluminium to allow the circulation of temperature adjusted water. For 
normothermic animals, warm water (37°C) was circulated around the polythene 
tube and the aluminium table  A thermocouple wire connected to a 
thermocouple controller (Thermoalert TH-5, Columbus Instruments, Columbus, 
OH, USA) was placed in the oesophagus to continuously monitor core 
temperature.  Temperature was cooled from 37°C to 15°C over 60-90 mins 
(Figure 3.1).  Animals then remained at 15°C for 3 hours before being gradually 
rewarmed to 37°C, again over 60-90 mins.  Effort was taken to ensure that 
cooling and rewarming times were consistent between animals.  Normothermic 
animals remained at 37°C for 5 hours. Previous work using this experimental 
model has used 4 hours of stable hypothermia (Tveita et al., 1996; Kondratiev et 
al., 2006). However, the decision to use 3 hours within this study was made to 
maximise the number of animals that would survive the procedure. 
Karen McGlynn, 2017  Chapter 3 
49 
 
 
Figure 3.1: Temperature timeline for hypothermia rewarming in vivo surgery. 
Shown are the temperatures points where anaesthesia was switched off/on and also where 
respiration was supported. Normothermic animals remained at 37°C throughout. 
 
 
Haemodynamic measurements 
To assess ventricular haemodynamics during the in vivo procedure, a Millar P-V 
conductance catheter system was used (SPR – 838, Millar Instruments, Houston, 
TX).  This miniaturised (2.0 French) was inserted into the right carotid artery 
and advanced into the LV.  
Conductance catheter technology allows simultaneous measurement of pressure 
and volume within the LV and as such, the 4 phases of the cardiac cycle, 
isovolumic contraction, ejection, isovolumic relaxation and ventricular filling, 
can be conveniently visualised in a diagram (Figure 3.2). Under steady-state 
conditions and with a constant time interval between beats, this loop is 
repeated with each contraction. The use of P-V loop measurements are well 
established in rodents (Burkhoff et al., 2005; Pacher et al., 2008) and it serves 
as a particularly useful tool in the assessment of in vivo LV mechanical function 
during normothermia and hypothermia. 
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Figure 3.2: Pressure-volume loop. 
Idealised pressure-volume diagram highlighting the 4 phases of the cardiac cycle. 
 
The catheter measures relative changes in the conductance of blood during the 
cardiac cycle, reflective of ventricular filling and ejection during the cardiac 
cycle, which is then calibrated to achieve a measure of true volume. Special 
considerations related to the use of conductance measurements and volume 
determination are required at low core temperatures. The measured 
conductance should be corrected for parallel conductance induced by the 
alternating current passing through the blood into the surrounding LV wall or 
septum.  At the end of experiments, parallel conductance is usually measured by 
a bolus of saline (Kass et al., 1986). However due to the multiple temperatures 
used in this study, this method was not applied.  Blood viscosity is affected by 
temperature and the use of a saline bolus to calibrate at each temperature 
would be fatal. As a result of the lack of calibration, the measurements included 
parallel conductance (Lankford et al., 1990).   
To more accurately assess volume, the cuvette calibration method was used. 
Insulator-type cuvettes of known diameters (2-7mm) were filled with heparin 
treated blood. These were placed in a thermo-controlled water circulator 
allowing the temperature of the blood to be adjusted during calibration. 
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Therefore, the specific temperatures used in this experimental procedure could 
be corrected. Slopes and y-intercepts were applied to the analysis software to 
adjust conductance units to true volume units (µL) (Tveita and Sieck, 2012) 
 
LV pressure and volume signals were digitized at 1Hz, and recorded by 
ADInstruments Chart software.  The recorded data was analysed off-line using a 
cardiac PV loop analysis program (LabChart7). Recorded data included;  
 
Heart Rate (HR) 
Stroke Volume (SV): End diastolic volume (EDV) - End systolic volume (ESV) 
Cardiac Output (CO): Volume of blood pumped per minute  
dP/dtmax: maximum rate of pressure change in the ventricle 
dP/dtmin: minimum rate of pressure change in the ventricle 
Stroke Work (SW): the work done by the ventricle to eject a volume of blood 
(i.e. SV) into the aorta.  
LV end systolic pressure (Pes): The maximal pressure developed by the ventricle 
during systole. 
 
Additionally, to assess peripheral vascular responses, a fluid filled catheter (22G) 
attached to a pressure transducer was inserted into the left femoral artery to 
measure mean arterial pressure (MAP: average arterial pressure during a single 
cardiac cycle). 
 
In vivo assessment of ECG  
Electrocardiogram (ECG) recordings to assess the electrical activity of the heart 
during hypothermia and rewarming were carried out using lead II ECG limb leads. 
This method was advantageous as it did not require any further invasive 
procedure to provide an assessment of the electrical activity of the heart.  ECG 
signals were amplified and recorded on LabChart7. The main ECG parameters 
extracted from the software were PR, QRS and QT intervals (Figure 3.4). 
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Corrected QT (QTc) was also measured using Fridericia’s formula to correct for 
HR variability.  The software used was semi-automated with cursors identifying 
the different complexes of the ECG, these could be manually over-ridden if 
required. Reliable measurements require traces of a good quality, this can be 
problematic during cooling and rewarming as the animal will display a shivering 
response whereby the leads will experience a lot of movement. Recording for 
ECG was therefore continuous throughout the whole experiment and only traces 
with clear P, QRS and T waves were included in the results.  
 
A     B 
 
Figure 0.3: ECG….. 
 
 
 
 
Figure 3.4: In vivo ECG measurements. 
A: Example of the parameters measured in a standard ECG complex. B: Example from 
LabChart7 analysis of ECGs in vivo. Shown are the automated peaks that had been detected 
by the programme, all of which could be adjusted manually. 
 
Langendorff perfusion of hearts following in vivo cooling and rewarming 
Following rewarming, animals received an overdose of Na pentobarbital and 
hearts were rapidly removed and place in cold Tyrode’s solution. Hearts were 
then Langendorff perfused (see Chapter 2 for more details) with Tyrode’s 
solution at 37°C until perfusate ran clear.  Hearts were paced at 200ms (5Hz) via 
hook electrodes in the RA.  
 
Intraventricular pressure 
Hearts were given 15 minutes to physiologically stabilise before assessing LV 
function ex vivo.  As a measure of contractility, intraventricular function can be 
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measured using special, compliant balloons. These have been widely used and 
are effective in small rodents as a method of assessing cardiac function on 
isolated perfused hearts (Curtis et al., 1986; Sutherland et al., 2003).  The left 
atrium was trimmed and a balloon tipped (latex) catheter was inserted into the 
LV through the mitral valve. The balloon provided a closed system from which 
pressure measurements could be made, and intraventricular (i.e. left ventricular 
developed pressure [LVDP]) determined.  The balloon was attached to a fluid 
filled catheter and connected to a pressure transducer and bridge amplifier. 
 
Optrode recordings 
Following contractility measurements, hearts were perfused with mechanical un-
coupler Blebbistatin (3µM) to reduce contraction-based movement.  To assess 
the electrophysiology of these hearts, an optrode system was used (Cairn 
Research, UK). This fibre-optic light guide allowed near simultaneous recordings 
of optical APs and optical Ca2+ transients from the same site on the LV. Figure 
3.5 shows the fibre optic light-guide (2mm diameter) placed against the heart.   
 
Voltage  
50µL di-4-ANEPPS was added to the heart as a bolus just prior to recordings.  A 
light emitting diode (LED) emitted light at 470nm to excite the dye, with 
emission spilt at 580nm and measured at wavebands 550nm and 650nm. To 
minimise the effect of bleaching this LED was only switched on for 5 sec 
intervals to record a train of APs.  
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A     B 
 
 
Figure 3.5: Optrode placement on heart. 
A: Optrode placed against LV. Example recording of B: AP and C: Ca2+ transient. 
 
 Ca2+ measurements 
To record Ca2+ transients Fura-4F was used.  As described in Chapter 2, Fura-4F 
is excited at 340nm and 380nm, with emission collected at 510nm. The benefits 
of this is allowing for a ratiometric measurement of emitted fluorescence to be 
taken due to two excitation wavelengths.  However, excitation at 340nm is 
difficult using the current LED based system as the emitted wavelengths are of a 
very low power. For this reason, Fura-4F was excited with a 360nm light from a 
longer wavelength LED.  This wavelength is referred to as the isobestic point as 
it represents a Ca2+ insensitive sector of the excitation spectrum (Figure 2.3). It 
is still possible to yield a ratiometric measurement of Ca2+ using this approach. 
Prior to Fura-4F loading, background readings were taken. 30µM Fura-4 was then 
perfused onto the heart over 5 minutes.  This was carried out at half the normal 
perfusion rate to allow time for the Fura-4F to enter the heart.  Additionally, 
2.5mM probenecid (Sigma Aldrich, Saint Louis; MO, USA)) was added to the 
Tyrode’s solution and perfused onto the heart to inhibit anion transport and 
prevent Fura-4 secretion. The heart was left for a further 10 minutes to allow 
the acetomethyl groups to be removed by intracellular esterases. Recordings 
were then made by exciting with a 360nm optoLED (5secs) and then immediately 
switching to 380nm optoLED for a further 5 secs. Fluorescence was collected at 
510nm.   
C 
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Near simultaneous AP and Ca2+ recordings could be carried out on each of the 
hearts due to the different excitation wavelengths.  By switching between 360, 
380 and 470nm at 5 sec intervals it was possible to make sequential ratiometric 
recordings of both APs and Ca2+ transients. 
 
 Analysis 
Signals were recorded using WinEDR software (SIPBS; University of 
Strathclyde,UK) and analysed using custom software developed in house 
(F.Burton; University of Glasgow, UK): RatioAverager for APs and CellOPTIQ for 
Ca2+ transients.  These programmes averaged recorded signals to a mean AP/Ca2+ 
transient. Parameters such as time between 10 and 90% of the upstroke (Trise), 
time to peak (Tpeak), amplitude and duration of transients could be measured.    
 
 Statistical analysis 
Data are expressed as mean ± SEM. Haemodynamic and ECG measurements were 
assessed by one-way ANOVA for repeated measures. Optrode data 
(normothermic vs hypothermic) was compared using an unpaired t-test. When 
significant differences were found, data were post-hoc analysed using Tukey’s 
test. All statistical tests were performed using GraphPad Prism software. 
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Results 
Haemodynamic measurements  
Animals either underwent a normothermic (n=9) or hypothermic (n=9) surgical 
procedure. All animals except one in the hypothermic group survived.  This 
animal developed VF at 30°C upon rewarming. In this instance only 
haemodynamic measurements recorded during cooling were included, with all 
rewarming data excluded. Figure 3.5 shows typical PV loop traces from hearts at 
37°C and 15°C, with considerable effects on both pressure and volume evident.  
 
 
Figure 3.6: Pressure-volume loops at 37°C and 15°C.  
Representative trace from one animal at baseline (37°C) and during stable hypothermia (3 
hours at 15°C). 
 
Hypothermia and rewarming 
Cooling to 15°C showed significant changes in all haemodynamic measurements 
(Figure 3.7, left panel).  Following 3 hours of stable hypothermia, MAP 
decreased by 71.9 ± 2.4% (117.8 ± 3.9 vs 33.8mmHg, p<0.05) when compared to 
37°C baseline.  Gradual rewarming returned MAP to within baseline.  HR 
gradually decreased and after stable hypothermia was reduced by 84.2% (427.6 ± 
11.1 vs 64.2 bpm, p<0.05).  Rewarming to 37°C increased HR, to 115.5 ± 15.1% 
(494.1 ± 8.9 bpm) which was not different from baseline values.  CO showed an 
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initial increase to 147.6 ± 17.6 % (vs 37°C, p<0.05) when cooled to 34°C, which 
then gradually decreased as cooling continued (Figure 3.7C).  Following 3 hours 
of stable hypothermia at 15°C CO had decreased by 82.3 ± 1.1% (p<0.05).  Upon 
rewarming to 37°C, CO did not return to baseline values, showing a reduction of 
35.7 ± 4.1% (p<0.05). Due to errors with the cuvette calibration equation, the 
absolute values of CO and SV, when compared to previous data from the lab, 
were out by a factor of 10, and as a result are only presented as ]%. Despite 
this, the reduction in CO upon rewarming was evident in all hearts. SV increased 
throughout cooling to a maximum of 238.4 ± 32.8 % of baseline at 15°C (p<0.05) 
however normalised following 3 hours of stable hypothermia (141.2 ± 25.1%).  
Rewarming did not significantly change SV when compared to pre-hypothermic 
values however there was a  trend towards a reduction (100 ± 0.0 vs 65.5 ± 
8.6%). 
Ventricular performance during hypothermia and rewarming was also assessed by 
examining dP/dt max and min.  dP/dt max (Figure 3.7E) showed a similar trend 
to CO, with an initial increase during cooling. At 32°C it was increased to 150.6 
± 7.3% of baseline (15,277.5 ± 1011.5 vs 10,256± 756.1 mmHg/s, p<0.05), 
however further lowering of temperatures showed a decrease in contractility.  
During stable hypothermia dP/dt max had decreased by 89.2 ± 1.4 % when 
compared to 37°C (p<0.05), however it normalised upon rewarming. dP/dt min, 
SW and end systolic pressure all showed significant reductions during cooling to 
15°C (p<0.05) but returned to baseline values upon rewarming to 37°C. These 
haemodynamic results confirm that animals in the hypothermia group had 
evidence of cardiac dysfunction or ‘rewarming-shock’. 
 
Normothermia 
Data from normothermic control animals can be seen in Figure 3.7 (right panels).  
No differences were found in any haemodynamic measurements throughout the 
5-hour in vivo procedure.   
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Figure 3.7– Haemodynamic measurements from in vivo surgery. 
Left panel shows measurements during cooling and rewarming whilst right panel shows 
normothermic control data. All data presented as percentage change from baseline (37°C) A: 
MAP B: HR C: CO D: SV *p<0.05 compared to 37°C. Continued overleaf. 
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Figure 3.7 Haemodynamic measurements from in vivo surgery cont.. 
Left panel shows measurements during cooling and rewarming whilst right panel shows 
normothermic control data. All data presented as percentage change from baseline (37°C) E: 
dP/dt max. F: dP/dt min. G: SW. H: Pes. *p<0.05 compared to 37°C baseline.  
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In vivo assessment of ECG  
ECG was recorded in all animals throughout cooling and rewarming via 3 limb 
leads. Figure 3.8A shows example traces from different temperatures.  Traces 
from several animals were excluded due to the noise in the signal. Due to 
missing data, statistical analysis was carried out using a One-Way ANOVA (Tukeys 
post hoc).  This differed from the Repeated Measures test carried out for the PV 
loop data, which may explain some differential findings. 
   
Hypothermia and rewarming 
Cooling to 15°C slowed both HR and prolonged ECG parameters (Figure 3.8B/3.9, 
left panels). As seen with the P-V loop recordings in the previous section, there 
was a significant slowing of HR (404.1 ± 6.9 vs 55.3 ± 6.3 bpm, p<0.05) during 
cooling. However, upon rewarming HR increased above baseline values (477.9 ± 
9.1 vs 404.1 ± 6.9, p<0.01), a finding not replicated in the P-V loop analysis.  
Following 3 hours of stable hypothermia there was significant slowing of both the 
PR (43.7 ± 2.1 vs 291.5 ± 21.1 ms, p<0.05) and QRS (31.9 ± 9.2 vs 86.7 ± 6.5 ms, 
p<0.05) intervals when compared to 37°C baseline. Clear T waves were not 
always evident in ECG traces. Therefore, the QT and heart rate corrected QT 
(QTc) are from n=4 in the hypothermic group and n=3 in the normothermic 
group.  The differences in the values at 37°C are quite evident, with a QT 
interval of 59.9 ± 16.8 ms compared to a QTc value of 112.7 ± 31.2 ms. Both 
parameters showed the greatest slowing following one hour of stable 
hypothermia, but returned to within baseline values upon rewarming.   
 
Normothermia control 
Data from normothermic control animals can be seen in Figure 3.8/9 (right 
panels).  No differences were found in any ECG parameters throughout the 5-
hour in vivo procedure.   
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Figure 3.8: ECG traces and heart rate data from in vivo surgery. 
A: Example traces of ECG recorded using 3 limb leads. Shown are the temperatures recorded 
during hypothermia and rewarming (i) and also normothermic control animals (ii).  B: Heart 
rate data from ECG leads. Left panel (i) shows measurements during cooling and rewarming 
whilst right panel (ii) shows normothermic control data. *p<0.01 compared to compared to 
37°C baseline. 
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Figure 3.94 ECG measurements during in vivo surgery. 
Left panel shows measurements during cooling and rewarming whilst right panel shows 
normothermic control data. A: PR interval. B: QRS interval. C: QT interval. D: Corrected QT 
interval (QTc) using Fridericia’s correction formula. *p<0.01 compared to 37°C baseline. 
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Langendorff perfused heart preparation following in vivo surgery 
Following rewarming to 37°C hearts were removed and Langendorff perfused 
with Tyrode’s solution.  Initial experiments on separate non-surgical animals 
attempted to minimise multiple temperature changes to hearts.  These animals 
(n=2) were euthanised and hearts removed and placed in Tyrode’s solution 
warmed to 37°C. However, because these hearts continued to beat it was 
technically very difficult to mount them onto the Langendoff cannula without air 
entering the coronary vessels. For this reason, all subsequent experiments used 
cold Tyrode’s solution. 
 
Intraventricular pressure recordings on isolated rewarmed hearts 
Pressure measurements were made on a subset of hearts (n=3 in each of 
normothermic and hypothermic groups) from a balloon inserted in the LV (Figure 
3.10). Hearts that underwent the in vivo surgery but remained at 37°C 
throughout displayed normal pressure traces.  In contrast to this hearts that had 
been rewarmed following 3 hours of hypothermia began to fibrillate immediately 
upon placement on the balloon. These hearts were given time to recover (bolus 
of KCl used where necessary) however any adjustment to the balloon 
(inflation/deflation) caused the hearts to go into an abnormal rhythm. 
Comparisons between hypothermic and normothermic hearts were not made due 
to the irritability of these hearts.  
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Figure 3.10: Inter ventricular pressure on hearts isolated post-surgery. 
Hearts removed following surgical procedure and Langendorff perfused.  Typical traces 
recorded by balloon placement in the LV. 
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Voltage measurements on isolated rewarmed hearts 
Due to the difficulties in obtaining intraventricular pressure measurements, 
separate hearts were used for the optrode recordings (hypothermia n=4, 
normothermia n=4).  AP differences can be seen in Figure 3.11A.  Hearts that 
underwent hypothermia and rewarming had a shorter AP than those that were 
maintained at a stable 37°C. Analysis of APs showed no difference in TRise, 
Tpeak or Trepol.  APD90 was significantly shorter in hypothermic hearts (Figure 
3.12) compared to normothermic controls (40.7 ± 1.1 vs 52.6 ± 3.8 ms, p<0.05) 
 
 
 
Figure 3.11: Voltage measurements on isolated hearts following surgery. 
Hearts removed following in vivo surgical procedure and Langendorff perfused.  Following 
loading with di-4 ANEPPS Optrode was placed against the LV.  A: Example traces of 
normothermic (red) and hypothermic (blue) APs. B: Rise time (TRise) of AP. C: Time to peak 
of AP. D: Time to Repolarisation 50%, 75% and 90% (TRepol50/75/90). Light grey bars 
represent hearts that underwent the normothermic surgery whilst black bars represent 
hearts that were cooled and rewarmed.  
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Figure 3.12: Action Potential Duration (APD) values from isolated hearts following surgery. 
Hearts removed following in vivo surgical procedure and Langendorff perfused.  Following 
loading with di-4 ANEPPS Optrode was placed against the LV.  A: APD 50%, 75% and 90% 
(APD50/75/90). Light grey bars represent hearts that underwent the normothermic surgery 
whilst black bars represent hearts that were cooled and rewarmed. *p<0.05 difference in 
APD90 between hypothemic and normothermic hearts. 
 
Ca2+ measurements on isolated rewarmed hearts 
Due to problems with equipment, Ca2+ transients were only available from 1 
normothermic and 2 hypothermic hearts, therefore it is not possible to draw any 
conclusions from the data. The main difficulties were that the traces were noisy, 
due to interference in the system and not physiological issues. Figure 3.13 shows 
parameters measured. Although no statistical tests were able to be used, there 
does not appear to be any difference in amplitude, Trise or Tpeak of the Ca2+ 
transients.  Time to 90% Ca2+ decay shows a trend towards a slowing (142.2 vs 
115.5 ± 20.8 ms) in the hypothermic hearts however further experimental work 
would be required to comment further.   
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Figure 3.13: Ca2+ transient analysis from isolated hearts following surgery. 
Hearts removed following in vivo surgical procedure and Langendorff perfused.  Following 
loading with Fura-4F optrode was placed against the LV.  A: Ca2+ transient amplitude 
(arbitrary units, AU). B: Rise time (TRise) of Ca2+ transient. C: Time to peak of Ca2+ transient. 
D: Time to 50/75/90% Ca2+ transient decay (Decay50/75/90). Light grey bars represent hearts 
that underwent normothermic surgery whilst black bars represent hearts that were cooled 
and rewarmed. 
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Part 2: Transient hypothermia and rewarming on isolated perfused 
rat hearts 
 
The aim of this work was to examine the effect of short term cooling and 
rewarming on cardiac electrophysiology.  The animals used in this work had not 
undergone any prior in vivo surgery. 
 
Methods 
Male Wistar rats (n=10) were given an intraperitoneal overdose of Na 
pentobarbital and hearts were removed and Langendorff perfused as previously 
described.  The optrode protocol was the same as described in the previous 
section.  
 
Transient cooling and rewarming 
Hypothermia was induced by running Tyrode’s solution through a water-coupled 
heat exchanger before allowing the solution to perfuse the heart.  Cooling from 
baseline (37°C) was achieved through reduction in the temperature of the water 
bath to 34, 32, 28, 25, 22, 20, 17 and 15°C.  Cooling to 15°C took approximately 
80 minutes, with hearts maintained at each target temperatures (± 0.2°C) for ~5 
mins prior to recordings.  Rewarming (to 22, 32 and 37°C) took approximately 25 
mins. RA pacing by hook electrodes was adjusted at each temperature (Figure 
3.14B). 
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Results 
Table 3.1 shows the number of hearts that signals were successfully acquired 
from during cooling and rewarming.  Voltage measurements were recorded from 
37°C down to 15°C and through rewarming.  Due to the length of the 
experiments, a second bolus of di-4-ANEPPS was required in most hearts.   No 
extra Fura-4F was required however Ca2+ transients recorded below 17°C had 
such a small amplitude that they were not able to be reliably analysed.  
 
Table 3.1: Voltage and Ca2+ heart data 
 Temp (°C) 37 34 32 28 25 22 20 17 15 22 32 37 
Voltage (n=) 10 7 7 7 7 6 7 6 5 4 5 5 
Ca2+ (n=) 5 7 7 7 7 4 5 1 - 2 3 4 
 
Shown are the temperatures used and number of hearts that voltage and Ca2+ data was 
acquired from. Shaded boxes refer to rewarming temperatures. 
 
Effect of transient hypothermia on action potential characteristics 
Transient cooling and rewarming showed distinct changes in AP morphology.  
Figure 3.14A shows typical AP traces from a single heart at selected 
temperatures though cooling and rewarming.  The AP from rewarmed hearts 
displays a markedly prolonged shape when compared to baseline.  Ventricular 
activation (TRise) progressively slowed through cooling, with temperatures 
below 22°C significantly different when compared to baseline (1.8 ±0.08 ms at 
37°C vs 22.17±1.22 at 15°C, p<0.05).  Rewarming returned Trise towards 
baseline values however it did not recover completely (5.83 ±0.7 vs 1.8 ± 0.1 
ms). This difference was not found to be different when applying a repeated 
measure ANOVA and post hoc analysis, however comparing these two points 
using a student t-test indicated a significant difference (p<0.01). Time to 
repolarisation (TRepol90) gradually slowed through cooling with temperatures 
below 25°C significantly different from baseline (p<0.05). 
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Figure 3.14 Voltage measurements on isolated hearts undergoing transient 
hypothermia/rewarming. 
Langendorff perfused hearts loaded with di-4 ANEPPS and optrode was placed against the LV. 
Cooled and rewarmed over 90 mins. A: Example traces of APs during cooling (37°C, 31°C, 
22°C and 15°C) and rewarming (22°C, 31°C and 37°C). B:  Stimulation Time (TStim), rate 
hearts were stimulated at throughout.  C: Rise Time (TRise). C: Time to peak (TPeak). D: 
Time to Repolarisation 50%, 75% and 90% (TRepol50/75/90). White circles refer to TRepol50, 
light grey bars to TRepl75 and black to TRepol90. *p<0.05 compared to 37°C baseline.  (Not 
shown on graph TRepol75, 28°C, 25°C, 22°C, 20°C and 17°C different to 37°C baseline, 
p<0.05). No differences observed between temperatures in TRepol50. 
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Mean APD differences can be seen in Figure 3.15. As shown in the example 
records there is a prolongation of APD throughout cooling and rewarming. APD90 
is significantly slower than baseline at temperatures below 32°C (p<0.001). At 
15°C APD90 is almost 3x longer than at 37°C (53.5 ± 2.6 vs 143.2 ± 10.1ms, 
p<0.05). Unlike activation parameters, rewarming from 15°C to 22°C showed an 
increase in APD90 (143.2 ± 10.1 vs 172.9 ±11.1 ms). Post hoc analysis using 
Tukeys test did not find this to be different, however comparison by paired t-
test showed that at 22°C APD90 was significantly longer than at 15°C (p<0.05). 
Rewarming to 37°C showed that APD90 remained prolonged with a duration 
almost double starting values (53.5 ± 2.6 vs 92.2 ± 4.9 ms, p<0.05). 
 
 
Figure 3.15: APD in isolated hearts during transient cooling and rewarming. 
Langendorff perfused hearts loaded with Di-4 ANEPPS and optrode was placed against the LV. 
Cooled and rewarmed over 90 mins. A: APD50/75/90. White circles refer to APD50, light grey 
to APD75 and black to APD90. *p<0.001 compared to 37°C baseline. # p<0.05 compared to 
37°C baseline. (Not shown on graph, all points that are different at APD90, also significant at 
APD75, p<0.05. For APD50, 31°C, 28°C, 25°C, 20°C, 17°C, 15°C, 22°C and 31°C different 
to 37 baseline, p<0.05. 
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Effect of transient hypothermia on intracellular Ca2+ 
Example traces of Ca2+ recorded from isolated perfused rat hearts during 
transient cooling and rewarming can be seen in Figure 3.16. Cooling showed non- 
significant variation in rise time and time to peak. Ca2+ transient decay 
(diastole) was prolonged at temperatures below 32°C and up to 32°C upon 
rewarming (p<0.05), however at 37°C no differences compared to baseline were 
detected.  Despite missing data at 15°C there does not seem to be a similar 
rewarming change in Ca2+ that was seen in APD90. 
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Figure 3.5: Optrode Ca2+ measurements during transient hypothermia and rewarming. 
Langendorff perfused hearts loaded with Fura-4F and optrode placed against the LV.  Cooled 
and rewarmed over ~100 mins. A: Example traces of Ca2+transients during cooling (37°C, 
32°C, 22°C) and rewarming (32°C and 37°C). B: Ca2+ transient amplitude (arbitrary units, 
AU). C: Rise time (Trise) of Ca2+ transient. D: Time to peak (Tpeak). E: Time to 50/75/90% 
Ca2+ transient decay (Decay50/75/90). Figures B, C and D: no data available below 20°C, E: 
no data available at 15°C. *p<0.05 compared to 37°C baseline. No differences were found in 
Decay50/75. 
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Discussion 
This chapter looked to examine the electrophysiology of isolated hearts 
following short and long term hypothermia. There are several key findings from 
this work, which are detailed below. 
 
Summary of findings 
Part 1 examined electrophysiology and mechanical function following an in vivo 
hypothermia/rewarming procedure: 
 
1 Animals that underwent an in vivo hypothermia rewarming procedure 
suffered from rewarming shock, with evidence of a reduction in CO at 
37˚C, and a compromised SV whilst other haemodynamic measurements 
stabilised. These findings are in line with previous studies on both dog 
(Prec et al., 1949;  Blair et al., 1956; Tveita et al., 1994) and rat models 
(Tveita et al., 1996;  Kondratiev et al., 2008).  
 
2 Whilst previous work using this model has used 4-5 hours of stable 
hypothermia (Tveita et al., 1996; Kondratiev et al., 2006a; Kondratiev et 
al., 2008; Wold et al., 2013), this study confirmed that after 3 hours there 
was a significant reduction in contractile function, indicative of the 
rewarming effect (Tveita et al., 2012). 
 
3 Following in vivo hypothermia and rewarming there is a shortening of 
APD90.  
 
Part 2 examined the effect of transient hypothermia on cardiac 
electrophysiology: 
1 Transient cooling and rewarming appears to affect cardiac behaviour in a 
different manner than long term in vivo cooling.  
 
2 Following transient hypothermia and rewarming there is a prolongation of 
APD90. 
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3 No change in intracellular Ca2+ upon rewarming was detected. This is in 
line with isolated cell findings from Chapter 3 which found no change in 
Ca2+ following a hypothermia/rewarming procedure. 
 
APD shortening following in vivo hypothermia and rewarming 
It has been extensively shown in experimental studies that hypothermia prolongs 
APD (Fedorov et al., 2008; Piktel et al., 2011; Egorov et al., 2012), however in 
this model of rewarming induced shock we have been able to show that there is 
a markedly shorter APD.  
 
Contraction is initiated by an action potential, and the action potential duration 
(APD) is determined by a critical balance between inward and outward 
membrane currents. The AP consists of 4 phases;  
Phase 0: rapid depolarisation, where the voltage dependent Na+ channel 
conducts a rapid inward current of Na+ (INa), which depolarises the myocyte 
leading to upstroke of the AP 
Phase 1:  early repolarisation, Na+ channels rapidly inactivate and a transient 
outward K+ current (Ito) causes early partial repolarisation 
Phase 2: the plateau contraction begins during this phase where a second inward 
current, mainly of extracellular Ca2+ ions (ICa) maintains a prolonged 
depolarisation. An inward Na+ current through NCX maintains the late stage of 
phase 2.  
Phase 3: final repolarisation, outward K+ currents (IKv and IKir) terminate the 
plateau 
 
The shortening of APD that we see in this study could be as a direct result of the 
anaerobic environment that develops in hypothermia/rewarming. In other 
situations, where metabolic inhibition has occurred (e.g. ischaemia and 
hypoxia), the ATP-sensitive K+ (IK(ATP))channel has been implicated as a cause of 
APD shortening (Weiss and Lamp, 1989; Fujita and Kurachi, 2000; Tang et al., 
2012) and provides a link between cellular metabolism and excitability. Gated 
by intracellular nucleotides, ATP and ADP, this type of K+ channel can be found 
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on two subcellular membranes; sarcoplasmic (sarcoKATP) and mitochondrial 
(mitoKATP).  When ATP decreases, adenosine removes the ATP inhibition and 
opens the channels, of which there are a high density in cardiomyocytes (Donald 
M. Bers, 2002) and increases the K+ efflux, and shortening the APD. Evidence to 
support KATP channels as a contributor to shortening of APD has been determined 
from studying the effect of Gilbenclamide, a selective KATP channel blocker. 
Studies have shown that it is able to reduce or prevent APD shortening in 
hypoxia and ischaemia (Kantor et al., 1990; Venkatesh et al., 1991). It has been 
shown that low intracellular ATP (<0.1mM) is enough to activate less than 1% of 
channels, which can result in an APD shortening of ~50% (Weiss et al., 1992). 
Within this study, hearts that had been cooled and rewarmed showed a 
reduction in APD of ~20% when compared to normothermic hearts. Therefore, a 
small decrease in ATP could have activated the opening of these channels, 
terminating the AP early and this could be a component in reduced contractile 
force.  
 
It has previously been shown that ATP was significantly reduced both during 
hypothermia and rewarming (Ytrehus and Aspang, 1994), alongside an increase in 
Pi  (Tveita et al., 1996). In isolated myocytes it has been shown that ATP 
depletion inhibits the Na+/K+ ATPase leading to an increase in intracellular Na+. 
Alongside this there is a significant increase in K+ conductance due to the 
opening of KATP channels as a consequence of decreased ATP  (Lederer et al., 
1989). These findings, in combination with the results from this study suggest 
that metabolic consequences of hypothermia and rewarming are significant 
enough to cause activation of the KATP channels.   
 
APD prolongation following transient hypothermia 
Transient hypothermia showed a significant prolongation in APD in isolated rat 
hearts that didn’t recover upon rewarming.  APD prolongation is a common 
finding in hypothermia (Shattock and Bers, 1987; Yan and Antzelevitch, 1996; 
Mattu et al., 2002). During hypothermia it is know that ionic currents (e.g. ICa, 
INa, Ik Ica)  are affected by decreasing temperature (McDonald and Trautwein, 
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1978; ; Colatsky, 1980; Cavalié et al., 1985; Sprung et al., 1991; Kiyosue et al., 
1993; Puglisi et al., 1996).  
The findings from this study showed no change in AP rise time throughout 
hypothermia or rewarming which suggests that there is a change in repolarising 
currents that does not occur during sustained hypothermia.  
 
These results would suggest that transient cooling and rewarming is more 
detrimental to the heart than prolonged hypothermia. Whilst there is significant 
contractile dysfunction following in vivo cooling and rewarming, the AP has 
returned to a shorter duration. In contrast, rewarming hearts from transient 
hypothermia does not return AP to normal, suggesting that these hearts are 
more affected by the speed of which the low temperatures were induced.  
 
Conclusions  
Following in vivo hypothermia/rewarming where hearts showed a reduced 
contractile function there was a chronically shorter APD which suggests a 
sustained electrophysiological effect that would manifest as a shortened QT 
interval, a change that has been linked to arrhythmic behaviour in human hearts 
(Iribarren et al., 2014). This APD effect could potentially reduce the amplitude 
of the intracellular Ca2+ transient and subsequent contraction, but 
measurements of Ca2+ with Fura4 failed to detect a significant decrease in 
transient amplitude. Thus the reduced SV would appear to the result of reduced 
myofilament sensitivity to Ca2+. In contrast to this, a period of transient 
hypothermia has alternative detrimental effects on the cardiac APD when 
compared to prolonged hypothermia, an effect that would predispose to the 
induction of long QT related arrhythmias and ventricular tachycardia.
Karen McGlynn, 2017  Chapter 4 
78 
 
 
Chapter 4: Examination of the inotropic 
response in an in vitro model of 
hypothermia/rewarming  
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Introduction 
The mortality rate from accidental hypothermia remains high and has not 
improved in the last 40 years despite medical advances (Walpoth et al., 1997).  
The incidence of arrhythmias and cardiac output insufficiency that occur during 
rewarming are documented, however there remains an incomplete 
understanding of the underlying physiological mechanisms. 
 
Rewarming induced shock 
Whilst many studies focus on the physiological effects of cooling, there are 
substantial detrimental side effects that occur during rewarming from accidental 
hypothermia. The inability to maintain CO and blood pressure, known as 
“rewarming shock” is a common threat. 
 
Early canine studies examining hypothermia/re-warming found evidence of this 
‘rewarming shock’.  When cooled to 30-33°C, dogs displayed prolongation of 
systole and isovolumetric relaxation.  However, on rewarming to normothermia 
there was an immediate and rapid increase in heart and respiration rate that 
rose with temperature with evidence of circulatory collapse (characterised as 
low CO that didn’t return to normal, hypotension and diminished ventricular 
work) (Prec et al., 1949; Bigelow et al., 1950; Berne, 1954; Blair et al., 1956). 
More recently a reproducible experimental rat model of rewarming induced 
shock was developed. Anaesthetised animals were cooled to 13-16°C and 
maintained at this temperature for 4-5 hours before being rewarmed to 37°C. In 
line with the early canine work, data generated from this model has shown that 
upon rewarming from sustained severe hypothermia there is ~50% reduction in 
CO compared to baseline values (Tveita et al., 1996; Kondratiev et al., 2006a; 
Kondratiev et al., 2006b).  HR and blood pressure were maintained as was 
oxygen supply and the relative oxygenation of cardiac tissue but this was 
alongside a substantially reduced CO. This lowered CO would not normally be 
compatible with adequate perfusion of the tissue and the cellular basis for this 
remains unclear.  
 
In terms of therapeutic hypothermia, a similar cardiac deterioration has been 
reported following surgery, however in such cases this is attributed to 
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myocardial stunning, where mechanical dysfunction persists after the restoration 
of blood flow following ischaemia (Chalkias and Xanthos, 2012).  
The findings from the previous chapter showed that there was a significant 
reduction in CO. This would suggest that it is a cardiovascular response, however 
although the SV was not significantly different upon rewarming, there was a 
trend towards a reduction upon rewarming to 37C.  CO depends on both SV and 
HR, however in order to determine whether the rewarming dysfunction is 
cardiovascular or peripheral response we aimed to assess whether rewarming 
shock could be recapitulated in vitro using isolated ventricular myocytes.  
 
Cellular contractile dysfunction and temperature 
In order to understand the mechanisms involved in rewarming shock it is 
necessary to consider the fact that cardiac contraction is a result of the process 
of EC-coupling.  There has been a vast amount of research into the mechanisms 
involved in this process, in both whole heart preparations but also in isolated 
cardiomyocytes (Fabiato, 1985; Frampton et al., 1991; Hattori et al., 1991; 
Satoh et al., 1997).  
 
It is well established that hypothermia leads to a positive inotropic response 
which causes an increase in the magnitude of cardiac contraction (Langer and 
Brady, 1968; Bjornstad et al., 1993).  One study showed that when cooling rabbit 
ventricular muscle from 37˚C to 25˚C there was a 400% increase in force 
production (Shattock and Bers, 1987).  Changes in contractile function have been 
observed across species, and hypothermia has been shown to increase the 
amplitudes of contraction recorded from rabbit, ferret and cat cardiomyocytes 
at 25˚C (Puglisi et al., 1996).   
  
Conversely, rewarming has been associated with a negative inotropic response. 
Previous work has shown that following a period of hypothermia and rewarming, 
hearts displayed a Ca2+ content that was six to seven fold greater than control 
hearts (Kondratiev et al., 2008). A recent study therefore investigated whether 
an increase in global Ca2+ may be a possible reason for cardiac insufficiency upon 
rewarming. Using the same animal model as the previous study, Wold et al 
(2013) examined whether the reported Ca2+ increase occurred during the 
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hypothermia or rewarming stage. They found that the rise in global myocardial 
Ca2+ was present following 4 hours of severe hypothermia (15˚C) and that it 
remained elevated following rewarming. Based on these results, they suggested 
that the Ca2+ overload was as a result of the hypothermia, and that the 
dysfunction seen following rewarming was not induced by the rewarming process 
per se.   
 
It is clear that reducing temperature has a marked influence on many 
components of EC-coupling, and whether the dysfunction we see on rewarming is 
a consequence of the cooling, or from the increasing temperatures remains 
unclear.  Animal models have provided a vast amount of data; however, a similar 
model has not been reproduced in vitro to assist in providing a better 
understanding of this process. 
 
Aims 
The main aim of this chapter was to assess whether ‘rewarming shock’, a 
phenomenon evident in vivo, could be recapitulated in an in vitro model using 
isolated rat ventricular cardiomyocytes.  
  
Karen McGlynn, 2017  Chapter 4 
82 
 
Methods  
Cardiomyocyte Isolation  
Male Wistar rats (250-300g) underwent a Schedule 1 procedure in accordance 
with Home Office Guidelines.  Animals were stunned followed by a cervical 
dislocation causing both ascending and descending injury to the spinal cord and 
brain stem. The xiphoid process was identified and the thoracic cavity was 
opened to allow the rapid removal of the heart which was subsequently placed 
in an ice-cold perfusion buffer containing Krebs solution and heparin (25IU/ml) 
for anti-coagulation.  Excess tissue was trimmed before the heart was mounted 
and tied via the aorta onto the cannula of a Langendorff perfusion system 
(Figure 2.1).  Hearts were perfused (12ml/min) with Krebs solution (37°C) until 
blood cleared from the coronary vessels and perfusate ran clear. Perfusion was 
then switched to a Krebs solution containing 0.05% (w/v) bovine serum albumin 
(BSA) and type 1 collagenase (0.68mg/ml) to dissociate single ventricular 
myocytes. Once the initial solution had run through, the enzyme was collected 
and re-circulated. Enzymatic digestion was continued until tissue felt softened 
to the touch, in most cases this was between 12-14 minutes. Hearts were 
removed from the perfusion system and ventricles diced into small segments in 
KB solution containing 0.5% (w/v) BSA. Tissue was gently triturated with a 
Pasteur pipette in order to dissociate myocytes and the supernatant filtered 
through polyamide mesh (pore size 250µm) before being re-suspended in KB 
solution. Cell solution was gradually brought up to 1.8mM Ca2+ concentration 
using CaCl2. This was carried out in a stepwise manner using increasing Ca2+ 
concentration over a period of 60 min. 
 
In vitro cooling and rewarming  
Ventricular myocytes from each animal were split into hypothermic and 
normothermic groups.  For the hypothermia group, the cell suspension was 
gradually cooled by lowering the temperature of the waterbath that the 
Eppendorf was semi-immersed in.  Cooling to 15°C took approx. 20 mins and was 
maintained for 4 hours. Myocytes were either stimulated (MyoPacer Field 
Stimulator, IonOptix) at 1Hz (40V; 2ms duration) at 15°C for 4 hours to ensure 
contractile activity or remained as a quiescent control. Samples of cells were 
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taken at each time point and gradually rewarmed to 37°C over 10 min. A metal 
heat plate was used to ensure temperature remained at 37°C throughout 
measurements. A further control group of ventricular cardiomyocytes underwent 
the same dissociation protocol but were maintained at 37°C for 4 hours 
(stimulated and quiescent). 
 
Cell Shortening 
Cardiomyocytes were placed in a cell chamber (CellMicroControls, Norfolk, VA, 
US) (Figure 4.1) which was then secured onto a heat plate. Cells were allowed to 
settle for 10 minutes then were perfused throughout experiments with 1.8mM 
Ca2+ Krebs (37°C) to ensure availability of substrates for contraction and to 
maintain rewarming temperature. Temperature was monitored via the 
thermistor in the cell bath. Individual myocytes were identified and twitch-
stimulated by electrical field stimulation at a set frequency of 1Hz at 2ms 
duration (DS2A and DG2A, Digitimer Ltd) via the stimulation electrodes on either 
side of the chamber.   
 
Video-based edge detection was used to record cell shortening with each 
contraction detected by light microscopy (Light source: Optoled lite - Cairn 
Research Ltd, Faversham, UK; Microscope: Nikon Diaphot 200, 40x objective).  
The velocity of contraction and relaxation and the amplitude of cell shortening 
was measured using light/dark contrast of the cell using signals which followed 
the left and right edges of the myocyte (Figure 4.2). These cell tracers were 
used to determine the relative cell length and calibrate it to absolute cell 
length. Both the left and right edges were scanned from the outside in to 
maximise edge detection. Images were digitised and viewed in IonWizard6.1 
(IonOptix Ltd). Analysis of the traces (Figure 4.2B) provided information on the 
time course of contraction and relaxation and the relative fractional shortening 
(FS).  
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Figure 4.1: Cell bath  
Cell bath chamber has an inflow tube and an area for aspirating solution. The 
stimulator/thermistor assembly presses into the chamber holder, this design allowed the 
monitoring of temperature of solution in the bath. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Cell shortening recording 
A: Brightfield image of Isolated ventricular myocyte. Arrows refer to the tracking of the left 
and right edges for edge detection. B: Example trace of fractional shortening (FS).  C: 
Parameters measured by IonWizard (semi-automated). FS is expressed at percent (%) 
difference between baseline length (diastole) and peak height (systole). 
  
A B 
C 
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Intracellular Ca2+ recordings following hypothermia and rewarming 
Intracellular Ca2+ was measured in cardiomyocytes following the hypothermic 
and rewarming protocol. Myocytes were loaded with 5µM of Ca2+ sensitive dye 
Fura-4F (Chapter 2). Cells were suspended in dye for 10 min at 15°C. Cells were 
then centrifuged, supernatant removed and re-suspended in Krebs solution 
(1.8mM Ca2+) and rewarmed to 37°C. Myocytes were then stimulated in the same 
manner as for cell shortening.  Cells were loaded with Ca2+ sensitive Fura-4F 
prior to rewarming in the hypothermic group and at 3 hours in the normothermic 
control group. Recording of Ca2+ transients was by epifluorescence microscopy 
(Nikon eclipse T/C. 40x/1.3 NA oil-immersion lens).  In order to eliminate 
background fluorescence an aperture was placed around the cell so that there 
were no other cells in the optical field. Myocytes were excited using a xenon arc 
lamp as a light source with a monochromator transmitting at 340 and 380nm 
wavelengths alternatively at 6ms intervals, and fluorescence emission was 
recorded through one photomultiplier tube (PMT) at 510 nm, with transients 
viewed in IonWizard 6.1. The optical settings for the epifluorescence are 
described in Figure 4.3. Analysis of the traces provided information on the time 
course of Ca2+ transient decay, amplitude and time to peak.  
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Figure 4.3: Schematic of optical settings for epifluorescence microscopy. 
Light from the xenon arc lamp is directed onto the monochromator which displays light at 
340nm and 380nm. The monochromator alternates between each excitation wavelength at 
6ms intervals. Emitted fluorescence passes through a long pass (LP) filter at 500nm to split it 
from the excitation wavelength. A further LP filter at 585nm directs emitted light to a photo 
multiplier tube (PMT) through a band pass (BP) filter at 505-530nm, which corresponds to 
Fura 4F emission wavelengths. Light of wavelengths longer than 600nm (from microscope 
lamp) was directed to the CCD camera to enable cell edge detection measurements.  
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Sarcomere length assessment during cooling and rewarming 
Separate experiments used a custom made cooling plate to ensure rate of 
temperature change was the same in all experiments (Figure 4.4). 
 
 
Figure 4.4: Cooling plate design 
Metal plate that cooled cells to 17°C and rewarmed to 37°C. Two 35mm dishes were fitted 
into the plate, one of which was stimulated by graphite electrodes throughout the 3 hours, 
whilst the other remained as a quiescent control. 
 
Two wells of myocytes were either cooled or maintained at 37°C, one stimulated 
at 1Hz (MyoPacer, 2ms, 40V) whilst the other remained quiescent. Cells could 
then be identified and the co-ordinates stored, therefore the same cells could 
be recorded at multiple time-points, before, during and after hypothermia. The 
throughput of this system was considerably higher than the previously described 
method and so an average of 10-15 recordings were made at each time point. 
Cells were identified and position was recorded on the CellOptiq 
electrophysiology platform (Clyde Bioscience Ltd., Glasgow, UK). Sarcomere 
length shortening was calculated using a system which utilised a high resolution 
digital camera (Hamamatsu C11440) in conjunction with a multiple objective 
Olympus microscope. Images of the contracting cell were recorded for 10 s 
(1000, frames/s) on HCImage Live (V4.2.003).  Analysis was carried out using an 
in house developed macro for ImageJ.  Examination of the recorded average 
pixel intensity in each frame allowed the production of a graphical 
representation of contraction using a fast fourier transform (FFT) algorithm 
(Figure 4.5).  
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Figure 4.5: Assessment of sarcomere length. 
A: Brightfield image of cell, the yellow box was fitted over a section of visible sarcomeres. B: 
Example trace of sarcomere length shortening. C: Measurements taken from each transient. 
Contraction difference 50 (CD50). 
 
CellOptiq assay to study intracellular Ca2+ 
Cells were loaded with 8µM Fura-4F at the start of the experiment. Repeated 
measurements were then taken from the cells at the same time points as 
sarcomere length assessment. As with the previous Ca2+ measurements, an 
aperture was placed around the cell to eliminate background fluorescence.  
Myocytes were excited by an OptoLED (Cairn Research; Faversham, UK), 
alternating between 360 and 380nm with emission collected at 510nm. 
Recordings were made at 100Hz and could be viewed and analysed in custom 
software designed for this system (Dr Francis Burton, University of Glasgow). 
Ca2+ transients were averaged and amplitude and time-course measurements 
taken. 
 
Statistical analysis 
Data are presented as mean ± SEM, and assessed by unpaired t-test or one-way 
ANOVA for repeated measures where appropriate. Where significant differences 
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were found, data were post-hoc analysed using Tukey’s test.  All statistical tests 
were performed using GraphPad Prism software.  
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Results 
Contractility in isolated ventricular cardiomyocytes following 
hypothermia/rewarming 
 
This study looked at the effect of cooling and rewarming on contractility in 
isolated ventricular myocytes. Figure 4.6A shows example traces of FS from cells 
at 3 hours following hypothermia/rewarming or normothermia. Immediately 
following dissociation, FS was 8.9±0.4% (Figure 4.6). Following hypothermic 
incubation (15°C) and subsequent re-warming to 37°C, cells which had been 
paced at 1Hz throughout showed a reduction in FS of 38% (5.5±0.7%, p< 0.01), 
57% (3.8±0.6%, p< 0.001) and 54% (4.1±0.5 %, p< 0.01) at 2,3 and 4 hours 
respectively when compared to freshly isolated cells. Cardiomyocytes stimulated 
at 37°C for 4 hours showed a reduction when compared to fresh cells (p<0.05). 
In quiescent cells (Figure 4.6B(i)) a significant reduction in FS was also only 
evident at 4 hours following hypothermia/rewarming. When comparing quiescent 
and stimulated cells following hypothermia and rewarming, myocytes at 2 and 3 
hours were significantly different from one another, with stimulated cells 
showing a significantly lower FS (8.3±1.0 vs 5.5±0.7 and 6.4±0.9 vs 3.8±0.6, 
p<0.05). 
The reduced contractility evident following 3 hours of hypothermic incubation 
was not accompanied by a change in time to peak or time to relaxation (Figure 
4.6C/D). All measurements of contractility can be seen in Table 3.1. 
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Figure 4.6: Fractional shortening (FS) measurements in isolated ventricular myocytes. 
A: Example traces from fresh cells and following 3 hours at 15°C and 37°C (1Hz). Cells at 
15°C were rewarmed to 37°C prior to shortening measurements. Traces are representative 
of FS shortening but not other parameters. B: Mean fractional shortening in quiescent (i) and 
stimulated (ii) myocytes. C: Time to peak in quiescent (i) and stimulated (ii) cells, and D: 
Time to 50% relaxation in quiescent (i) and stimulated (ii) cells. n=12 at 0hrs, n=11 at 2hrs, 
n=9 at 3hrs, and n=4 at 4 hrs. Numbers refer to the number of animals that myocytes were 
isolated from *p<0.05, ***p<0.001 
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Intracellular Ca2+ measurements in isolated ventricular cardiomyocytes 
following hypothermia/rewarming 
In separate experiments the role of Ca2+ was assessed in a bid to understand the 
reduced contractile function of isolated myocytes following hypothermia and 
rewarming. Whilst the previous results showed that at 4 hours there was reduced 
FS, the number of viable cells was vastly reduced compared to earlier time 
points. This, combined with the finding of a significant effect of 
hypothermia/rewarming at 3 hours led to the decision to assess Ca2+ at a 3-hour 
time-point in all subsequent experimental work. Cells were loaded with Ca2+ 
sensitive Fura-4F prior to rewarming in the hypothermic group and at 3 hours in 
the normothermic control group.   
 
Figure 4.7 shows typical Ca2+ transients at 0hrs (fresh cells) and following 3 hours 
in hypothermic and normothermic conditions (stimulated at 1Hz). No differences 
were found in Ca2+ transient amplitude between fresh myocytes and following 
cooling/rewarming, in either the quiescent or 1Hz stimulated group. Similarly, 
there was no significant differences in time to peak or the decay time of the 
Ca2+ transient when comparing hypothermic and normothermic cells after 3 
hours. Therefore, the first part of this study was able to find that 
hypothermia/rewarming leads to significant contractile dysfunction in cells 
which is not accompanied by a change in intracellular Ca2+. 
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Figure 4.7: Ca2+ measurements in isolated ventricular myocytes. 
A: Example traces (not averaged) from fresh cells and following 3 hours at 15°C and 37°C 
(1Hz). Cells at 15°C were rewarmed to 37°C prior to shortening measurements. B: Ca2+ 
transient amplitude in quiescent (i) and stimulated (ii) myocytes. C:  Time to peak in 
quiescent (i) and stimulated (ii) cells, and D: 90% Ca2+ transient decay time. n=10 
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Assessment of sarcomere length during cooling and rewarming 
The previous work has shown evidence of contractile dysfunction in isolated 
myocytes when cooled and rewarmed. Due to the system used for these 
measurements, cells were cooled separately and samples taken at each time-
point, therefore measurements were made on different cells each hour. The 
work presented in both this and the following section was carried out using a 
system whereby the same individual myocytes could be tracked throughout the 
cooling and rewarming procedure. This also ensured that the rate of 
temperature change was identical throughout all experiments.   
 
Figure 4.8 shows example traces of sarcomere length shortening alongside Ca2+ 
transients measured at the same time points. As cells could be ‘tracked’ through 
cooling and rewarming, measurements were taken every hour up to 3 hours. 
Quiescent cells were only measured at the end of the 3 hours.  
 
 
 
Figure 4.8: Typical traces of sarcomere shortening and averaged Ca2+ transients.   
Traces from one cell which was tracked through hypothermia and rewarming. At 1, 2 and 3 
hrs the cell was continually paced at 1Hz. 3hr (quiescent) is a separate cell.   
 
Sarcomere length results can be seen in Figure 4.9. Due to variations in baseline 
values between animals, all data is normalised. Cooling to 17°C more than 
doubled contraction time (Up90) at 1, 2 and 3 hours (p<0.05) when compared to 
fresh cells. Rewarming to 37°C returned contraction time to within baseline 
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values (at 1Hz). Quiescent rewarmed cells were also not different from starting 
values.   
 
Throughout the 3 hours of hypothermia there was no evidence of significant 
variation in amplitude. However, upon rewarming, the amplitude of shortening 
was 53% shorter than baseline (p<0.05). This difference was not seen in cells 
that were quiescent through the hypothermia. The reduction in amplitude in 
stimulated cells mirrors the FS data previously described, and reinforces the 
finding of a rewarming-induced contractile dysfunction in ventricular 
cardiomyocytes. The relaxation time course (Dn90) showed a high degree of 
variance but overall no differences during hypothermia or rewarming. 50% 
contraction duration (a marker of the time course of contraction increased 
during hypothermia (p<0.05) but normalised upon rewarming.  
Normothemic control cells which were maintained at 37°C for 3 hours showed no 
difference in any of the recorded parameters. 
 
Ca2+ measurements during cooling and rewarming using CellOPTIQ 
Intracellular Ca2+ was also measured in these cells immediately following 
sarcomere length assessment.  Cells were loaded with Fura-4F at room 
temperature prior to the experiment starting and measurements were made in 
the same cells throughout the 3 hours. Figure 4.9B shows averaged Ca2+ transient 
analysis. No differences were found in Ca2+ transient amplitude, time to peak or 
90% Ca2+ transient decay time during hypothermia or rewarming. Rise time was 
significantly slowed during the 3 hours of hypothermia (p<0.05) but normalised 
upon rewarming. These results reinforce the findings from the previous section 
that intracellular Ca2+ is not responsible for the contractile dysfunction that is 
seen upon rewarming from hypothermia. 
Normothemic control cells which were maintained at 37°C for 3 hours showed no 
difference in any of the recorded parameters. 
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Figure 4.9: Sarcomere length and intracellular Ca2+ measurements during 
hypothermia/rewarming. 
A: Mean sarcomere length recorded as an indicator of contractility function: (i) Time to peak 
contraction (Up90). (ii) Amplitude of contraction, (iii) Relaxation time (Dn90) (iv) 50% 
Contraction duration (CD50). B: Averaged Ca2+ transient results (i) Amplitude of Ca2+ 
transient, (ii) Rise time, (iii) Time to peak, (iv) Time to 90% Ca2+ transient decay. *p<0.05, 
**p<0.01.  
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Discussion 
The main aim of this work was to assess hypothermia and rewarming in isolated 
ventricular cardiomyocytes. Following hypothermia and rewarming, stimulated 
myocytes showed a reduction in contractile function that was not seen in 
quiescent or normothermic controls. These findings were confirmed by 
additional experimental work on a different system that allowed assessment of 
sarcomere length in hypothermic and rewarmed myocytes. The reduction in 
contractility was not accompanied by a change in intracellular Ca2+ transients. 
These findings are in line with a recently published study by Schaible et al  
(2016). Using a similar model to the one described in this chapter, they found 
that upon rewarming from hypothermia (3hrs) there was a shortening of ~3.5% 
compared to ~8% in freshly isolated cells. They also assessed Ca2+ throughout and 
whilst they witnessed an increase during the hypothermic phase, it normalised 
upon rewarming.   
 
The mechanisms underlying excitation contraction coupling and force generation 
appear to be disrupted following hypothermia and rewarming. This is in line with 
other animal models that have shown that systolic function or force generation 
is significantly reduced following hypothermia and rewarming (Zhang et al., 
1995; Tveita et al., 1998; Groban et al., 2002; Han et al., 2010). This could 
normally be explained by changes in cytoplasmic Ca2+ or sensitivity of the 
myofilaments to Ca2+. However, the results of the current study, as in the study 
of Schaible et al, found no change in cytosolic Ca2+. Taken together these results 
would suggest that the reduction in contraction is as a result of myofilament 
sensitivity, which has been shown to be temperature dependent in previous 
studies of cooling (de Tombe and Stienen, 2007) and rewarming (Harrison and 
Bers, 1989).   
 
It has been suggested that the underlying mechanism of hypothermia/rewarming 
induced contractile dysfunction may be due to high total cellular Ca2+ (Wold et 
al., 2013). Intracellular Ca2+ may increase in different cellular structures, e.g. 
SR, mitochondria or cytoplasm, and there are several different mechanisms by 
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which it could have an effect on myofilament sensitivity and contractile 
dysfunction;   
 
i. Mitochondrial damage 
Firstly, there is a potential role of metabolism in contractile dysfunction. Under 
normal circumstances the heart uses oxidative phosphorylation to provide 
metabolic energy for contraction. ATP is produced aerobically by the 
mitochondria and generates creatine phosphate (PCr) which shuttles the 
metabolic energy to the sites of energy consumption e.g. the contractile 
proteins, where it is used to re-phosphorylate local adenosine diphosphate (ADP) 
via creatine phosphokinase. When cytoplasmic Ca2+ rises, the myofilaments are 
activated in a Ca2+-dependent manner, thereby transducing the chemical signal 
and chemical energy (ATP) into mechanical force or shortening (Bers, 2002). If 
aerobic metabolism is prevented, e.g. by hypoxia or by damaged mitochondria 
then ATP can be generated anaerobically for a limited period of time. This 
switch to anaerobic metabolism comes with consequences for the heart, e.g a 
fall in PCr and subsequent rise in Pi. 
 
Ca2+ overload can lead to mitochondrial damage and a disruption in oxidative 
phosphorylation. When oxidative phosphorylation is inhibited, e.g. in hypoxia or 
due to mitochondrial damage, there is a decrease in contraction that isn’t a 
direct result of a decrease in systolic Ca2+ (Allen and Orchard, 1983). There are 
two possible metabolic changes which could be responsible; an increase in 
intracellular Pi concentration (Allen et al., 1985; Kusuoka et al., 1986), or an 
intracellular acidosis due to lactic acid build up following anaerobic metabolism  
and reduced contractility (Allen et al., 1985; Eisner et al., 1987). Separate 
studies on cardiac myofilament sensitivity showed that acidic environment and 
increased Pi both reduced force production in isolated hearts and papillary 
muscles (Fabiato and Fabiato, 1978; Kentish, 1986).   
 
However, experimental work on isolated rat cardiomyocytes with 
pharmacologically blocked mitochondrial function (cyanide) did not observe  
decreased cell shortening and contrasts with the work on whole hearts (Eisner et 
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al., 1989). The reason for the difference is unknown but may be related to the 
different measures of contractile activity, i.e. cell shortening (isotonic 
contraction) via force/pressure measurements (isometric). However, this latter 
study does suggest that hypothermia-induced reduced cell shortening is not due 
to blockade of mitochondrial metabolism. 
 
ii. PKA dependent pathway 
If metabolism is not the modifying factor in the reduced contractility, then 
myofilament sensitivity must be altered via another pathway. It has been 
proposed that myofilament Ca2+ sensitivity following rewarming may be due to a 
Protein Kinase A (PKA)-dependent phosphorylation of cardiac troponin I (cTnI).  
Briefly, beta-adrenergic stimulation activates adenylyl cyclase to produce cyclic-
adenosine monophosphate (cAMP), which activates PKA. This kinase 
phosphorylates several proteins related to EC-coupling, including L-type Ca2+ 
channels, RyR and troponin I ( Bers, 2002).  cTnI is a key regulatory protein in 
cardiac muscle contraction and relaxation, and phosphorylation by PKA results in 
a decrease in the sensitivity of the contractile apparatus to Ca2+. After 
phosphorylation the half-maximal ATPase activity and half-maximal tension are 
achieved at higher Ca2+ concentrations, an effect that may be due to decreased 
affinity of troponin I to troponin C (Filatov et al., 1999). Indeed the 
phosphorylation at specific sites (Ser23/24) on cTnI has been shown to be 
mechanistically involved in reduced myofilament sensitivity in various 
pathological situations (Gao et al., 1995; Tavernier et al., 2001; Chen and Ogut, 
2006). 
 
Following hypothermia and rewarming it has been shown that there is an 
increased cTnI phosphorylation in rat papillary muscle (Han et al., 2010) and in 
isolated ventricular cardiomyocytes (Schaible et al., 2016).  However, as yet 
there is no evidence to support Ca2+ overload in rewarming leading to increased 
cAMP activated PKA. 
 
Karen McGlynn, 2017  Chapter 4 
101 
 
iii. Oxygen derived free radicals 
A final mechanism which could cause the myofilament sensitivity and reduced 
contractile function in this study are oxygen derived free radicals. Changes in 
mitochondrial function as a consequence of increased total Ca2+ may lead to an 
increase in reactive oxygen species (ROS) which could in turn lead to 
mitochondrial dysfunction (Brookes et al., 2004). It has been shown that ROS can 
reduce Ca2+ sensitivity in skinned rabbit muscle fibres  (Perkins et al., 1997). 
Whilst it is believed that Ca2+ dysfunction plays a major role in the generation of 
ROS, the molecular mechanisms at this time remain elusive and further work is 
required, however it should be considered as a potential factor in hypothermia 
and rewarming. 
 
Conclusions 
This study has shown that hypothermia and rewarming can induce a contractile 
dysfunction in isolated cardiomyocytes. No change in Ca2+ transients would 
suggest that the dysfunction is as a result of altered myofilament sensitivity but 
it would be speculative to say what the underlying mechanism to this reduced 
force is at this time. 
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Chapter 5:  The differential effects of 
hypothermia on cardiac conduction and 
excitability 
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Introduction 
Accidental hypothermia is complicated by risk of ventricular arrhythmias and 
cardiac arrest. This contributes to high mortality rates among these patients, 
reported to be between 29% (van der Ploeg et al., 2010) and 80% (Maclean and 
Emslie-Smith, 1977) depending on rewarming methods. However, several case 
reports in recent years have demonstrated that successful resuscitation is 
possible even from core temperatures below 20°C (Wanscher et al., 2012). The 
apparent beneficial effect of hypothermia, i.e. reducing the detrimental effects 
of prolonged cardiac arrest, is utilised in aortic arch surgery, where severe 
hypothermia down to 15°C can be used (Di Luozzo and Griepp, 2012). 
Hypothermia has also been applied therapeutically in comatose survivors of 
cardiac arrest, where temperatures above 30°C are considered safe (Polderman 
and Herold, 2009). Although hypothermia is used extensively as a therapeutic 
intervention and survival is possible after extreme exposure, treatment of 
arrhythmias during rewarming is still challenging. Current guidelines provide only 
general suggestions for the use of defibrillator and preventative pharmacologic 
treatment (Vanden Hoek et al., 2010) when rewarming victims of accidental 
hypothermia. In order to develop targeted anti-arrhythmic strategies in this very 
specific situation, we first need to understand the basis for pro-arrhythmia 
during cooling and rewarming. 
 
In humans, hypothermia-induced arrhythmias commonly appear at core 
temperatures below 28°C, including atrial fibrillation, nodal rhythms, 
ventricular extra systoles, atrioventricular blocks and ventricular fibrillation (VF) 
(Tveita, 2000). The pathophysiology behind development of VF in the 
hypothermic heart remains unknown. Recent studies have shown that 
hypothermia can induce conduction block and re-entrant VF in canine wedge 
preparations. In this study VF or tachycardia was most common during 
rewarming, and was associated with transmural dispersion of repolarisation 
(DOR) (Piktel et al., 2011) and in a separate study epicardial DOR (Salama et al., 
1998). Combined with slowed conduction velocity (CV) at 30°C in rabbit hearts 
(Hsieh et al., 2009), these circumstances may favour unidirectional block and 
induction of VT/VF. Optical mapping of rabbit hearts cooled to 17°C have also 
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shown that severe hypothermia can induce spatial alterations in CV, a known 
predictor of VF (Egorov et al., 2012). However, it is unclear from previous 
studies whether electrophysiological changes and arrhythmic risk is directly 
proportional to the degree of hypothermia. 
 
Aims 
The aim of this chapter was to assess whole heart electrophysiology in isolated 
Langendorff perfused rabbit hearts using a series of techniques.  Measurements 
were carried out following gradual cooling and rewarming of hearts to 
temperatures occurring in therapeutic (31°C) and accidental (17°C) 
hypothermia. 
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Methods 
Langendorff perfused heart 
Male New Zealand White Rabbits (~3-3.5kg) were used for all experimental work 
in this chapter.  Hearts were isolated and Langendorff perfused (as described in 
Chapter 2).  Blebbistatin (10uM) was used for all of the following studies with 
the exception of whole heart conduction timings (section 5.2.3). Hearts were 
perfused with blebbistatin for 25 minutes prior to any measurements being 
made.  Due to the light sensitive nature of blebbistatin, all work was carried out 
with minimal room lighting. 
 
Hypothermia and rewarming protocol 
The temperatures used in this study were typical for moderate/therapeutic 
(31°C) and severe (17°C) hypothermia and are comparable to previous 
publications (Egorov et al., 2012). These temperatures are routinely employed 
therapeutically and observed in victims of accidental hypothermia, where core 
temperatures below 17°C have been reported in patients with a good 
neurological outcome after rewarming (Gilbert et al., 2000). Perfusion rate of 
hearts was constant (30 ml/min) during experiments. Whilst cooling to severe 
hypothermia in vivo decreases cardiac output, studies have also found coronary 
blood flow to be preserved or increased in hypothermia, partly because diastole 
is more extended than systole in cold animals (Tveita, 2000). In order to study 
electrophysiology under the same conditions at different temperatures, we 
therefore maintained perfusion at a constant rate. Hypothermia was induced by 
running Tyrode’s solution through a water-coupled heat exchanger, before 
allowing the solution to perfuse the hearts. Cooling from baseline (37°C) was 
achieved through gradual reduction of the temperature in the water bath. 
Cooling and rewarming between 37°C and 31°C took approximately 20 minutes 
each, while both cooling and rewarming between 31°C and 17°C took 30 minutes 
(Figure 5.1). This gradual change of temperature was carried out in order to 
mimic gradual whole body cooling and avoid rapid cooling contracture (Bers et 
al., 1989). Both cooling and rewarming was temporarily stopped for ~5 minutes 
at 31°C and 17°C to allow hearts to stabilise for recordings. Hearts underwent 
both right atrial (RA) and right ventricular (RV) pacing at cycle lengths of 300ms 
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at 37°C, 450ms at 31°C and 1700ms at 17°C.  These cycle lengths were based on 
previous work within the lab which assessed intrinsic heart rate using the same 
temperature protocol. 
 
 
 
Figure 5.1: Temperature timeline of experimental procedures.  Points 2-4 refer to the time 
where the heart was allowed to stabilise at each temperature (5 mins). 
 
Whole heart conduction timings 
After establishing Langendorff perfusion, a small section of the right atrium was 
removed and the anatomical region of the AV node (AVN) identified (n=6). A 
quadripolar electrode catheter (Figure 5.2) was then placed across the tricuspid 
valve adjacent to the AVN such that the proximal poles recorded atrial and 
ventricular activation times at the level of the AVN and the distal poles recorded 
activation in the RV apical endocardium. Additional catheter electrodes were 
placed in the RV against the septum and in the left ventricle (LV) against the 
endocardium. Finally, platinum hook electrodes were placed on the epicardial 
surface of the LV and into the RA to allow for pacing (Figure 5.7A). 
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Figure 5.2: Recording and pacing electrodes. A: Quadripolar electrode catheter.  B: Platinum 
hook electrodes 
 
Panoramic optical mapping  
In a subset of experiments, hypothermic (n=8) and normothermic (n=6) optical 
action potential characteristics were compared. Hearts were placed in a custom 
built chamber and perfused via a computer-controlled rotatable centrepiece 
connected to the aortic cannula, which allowed for easy rotation of the heart 
(Figure 5.3). Once the hearts were stabilised and aligned in the chamber, the 
preparation was stained with voltage sensitive dye, di-4-ANEPPS (100 µl of 1 
mg/ml). A pair of platinum hook electrodes was passed through the wall of the 
right atrium (RA); a second pair contacted the right ventricle (RV) for pacing. 
The heart was illuminated with an annular array of LEDs (OptoLED, Cairn 
Research Ltd.; Faversham, UK) with peak excitation wavelength 470 nm. Emitted 
fluorescence was collected, filtered with a long pass filter (665 nm) and 
focussed on a CCD chip (Redshirt Imaging; Decateur, GA USA). An area of 
epicardium ~43x43 mm was imaged at a working distance of ~140 mm. Images 
were acquired every 1ms at a resolution of 80x80 pixels. Using a stepping motor, 
the heart inside the chamber was rotated through fixed angles (± 120° from a 
central position) acquiring data sequentially from each viewpoint (LV, RV, 
posterior).  
 
Data analysis for the panoramic optical mapping was performed using custom 
software (Optiq; developed locally by F.Burton, University of Glasgow). The 
automated algorithm was able to detect selected AP trace characteristics. 
Activation time (TAct90) was determined as time to 90% of the OAP upstroke 
whilst repolarisation time (TRepol90) was time to 90% repolarisation.  Upstroke 
(Trise) was calculated as the time between 10% and 90% of activation time. 
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Action potential duration (APD90) was calculated by repolarisation time – 
activation time at the steepest upstroke. 
 
 
 
Figure 5.3: Optical mapping setup 
Hearts were Langendorff perfused and placed in a plexi glass chamber. In order to record 
panoramic images, a step motor turned the heart to LV, posterior and RV views during the 
experiments. A lens captured light emitted from the dye-loaded heart and a dichromic 
mirror split the light, which was projected on to the Redshirt or Dalsa camera. ECG was 
recorded through two metal bars in the fluid filled plexi glass chamber and the cannula 
connecting the heart to the Langendorff system.  (Schematic from Dr Erik Sveberg Dietrichs, 
University of Tromsø, Norway). 
 
ECG recording and analysis 
Pseudo lead-II ECG recordings were made using the steel bars in the custom built 
chamber (Figure 5.3).  These signals were amplified with a custom built 
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amplifier and displayed on an oscilloscope throughout experiments.  Alongside 
optical action potentials, ECG signals were recorded using a Redshirt Imaging 
control box digitiser (DAP820, Redshirt, Decatur, GA USA). Continuous recordings 
of ECG signals were made using a laptop computer with a USB compatible 
digitiser (DI-158, Dataq Instruments Inc; Akron, OH USA).  Signals were analysed 
using LabChart7 (ADInstruments; Sydney AUS) software (for full description of 
analysis see Chapter 4).  The main parameters examined in these hearts were 
PR, QR, QRS and QT intervals. 
 
Conduction velocity 
Conduction velocity (CV) was measured using custom-built electrodes which 
consisted of silver bipolar stimulating electrodes and two sets of silver bipolar 
recording electrodes (Channel 1 and Channel 2) which were fixed distances apart 
(Figure 5.4A). CV was recorded by pacing continuously at a fixed interval and 
recording the signals from the Channel 1 and Channel 2 recording electrodes (20 
kHz).  The difference in time between the peaks of both channels was taken as 
the difference in activation time.  As the distance between the electrodes was 
known, CV could be calculated using: V=d/t (where V = Velocity (cm/s), d = 
distance (cm) and t = time (s)). Recordings were made using software developed 
in house:  ACQ1 (F Burton, University of Glasgow). 
 
 
 
Figure 5.4 CV Electrode Design.   
A: Diagram of electrode design, showing the stimulating electrodes and two sets of recording 
electrodes.  X mm is the distance between electrode pairs and is between 1.6 and 1.8mm, as 
more than one set of electrodes was used during these experiments. B:  Example traces 
taken from an experiment showing the stimulus artefact and the peaks on the Ch1 and Ch2 
recording electrodes.  
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Initial CV experiments (n=4) looked at conduction in both the atria and ventricle. 
The electrodes were placed flat against the epicardium of the LV, and also 
against the surface of the RA.  CV was recorded throughout hypothermia and 
rewarming. 
 
Separate experiments (n=5) used two sets of electrodes to record CV in more 
than one axis. CV is dependent on fibre orientation with longitudinal conduction 
being ~2x faster than transverse conduction (Valderrabano, 2007). The epicardial 
surface has a fibre orientation such that the long axis of the cell runs ~90° from 
this angle to the vertical axis. Once the fastest conduction time in the long axis 
was identified, the electrodes were rotated 90° from this angle to record the 
transverse conduction (Figure 5.5). Such is the arrangement of fibres within the 
myocardium this is indicative of endocardial to epicardial (transmural) 
conduction. Both longitudinal (CVl) and transverse (CVt) conduction were 
recorded during hypothermia and rewarming.  
 
 
 
 
Figure 5.5: Electrode orientation 
Diagram showing the angle of the electrodes and the direction of propagation at 0° and 90°. 
 
Measurement of ventricular fibrillation threshold 
In separate experiments (n=7), ventricular fibrillation (VF) threshold was 
measured with RV endocardial electrodes. At each temperature, a train of 100 
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constant current pulses of 4 ms duration, 10 ms apart was delivered. The train 
spanned the refractory period at all experimental temperatures. Current 
strength was increased in steps of 5 mA until VF was sustained for a period 
longer than 4 secs. Between measurements, hearts were allowed to recover for 
1 minute after normal sinus rhythm was established. At each temperature, 
thresholds were averaged over 3 measurements according to the work of Cha et 
al (1993). 
 
Statistical analysis 
Data are expressed as mean ± SEM. Conduction time, VF threshold, optical 
imaging, ECG and CV measurements were assessed by one-way ANOVA for 
repeated measures. When significant differences were found, data were post-
hoc analysed using Tukey’s test. 
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Results 
ECG in isolated rabbit hearts during cooling and rewarming 
The mean changes in ECG measured from isolated Langendorff perfused hearts 
are shown in Figure 5.6. On cooling to 31°C, PR interval showed significant 
changes, increasing to 130% of normothermic baseline levels (73.3 ± 10.8 vs. 
97.8 ± 13.7 ms, p<0.05). QT interval also increased to 150% (178.8 ± 21.4 vs 
267.9 ± 32.6 ms, p<0.05) but changes in QRS and the QR intervals were absent; 
in particular QR interval was on average 99% of normothermic baseline values.  
During further cooling to 17°C both QR and QT time were prolonged, 
respectively (25.5 ± 4.1 vs. 53.8 ± 9.3 ms, p<0.05) (178.8 ± 21.4 vs. 591.8 ± 74.7 
ms, p<0.05). During rewarming to 31°C, QR interval returned to baseline values, 
but QT time was still prolonged (178.8 ± 21.4 vs. 294.1 ± 35.5 ms, p<0.05). After 
rewarming to 37°C, both parameters returned to baseline values. 
 
Whole heart conduction timings 
To examine electrical activity through the heart during cooling and rewarming, 
catheters were placed inside the right and left ventricles (Figure 5.7A). 
Example traces showing the relative timing of whole heart conduction can be 
seen in Figure 5.7B. Measurements were taken at the peak following maximum 
deflection (Figure 5.7C) representing the sequence of activation through the 
atria and ventricles. Typical records (Figure 5.7D) show that following 
stimulation, atrial conduction was unchanged at 31°C but considerably slowed at 
17°C. The first ventricular measurement, taken after the AV-node delay shows a 
steep increase in conduction time at 17°C that is not present at 31°C or 37°C. 
Karen McGlynn, 2017  Chapter 5 
113 
 
 
Figure 5.6 ECG parameters during cooling are rewarming 
A: Example ECG traces at 37°C, 31°C and 17°C. B: Percentage change of ECG characteristics 
during cooling and rewarming compared to normothermic baseline. *Significant difference 
between temperatures (p<0.05). # Significant difference between PR/QT intervals at 31°C 
and baseline (p<0.05). 
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Figure 5.7 Regional electrical activity measurements to assess whole heart conduction.  
A: Placement of electrodes indicated by dashed lines (1-2) trans AV node, (3) RV septum, (4) 
LV endocardium, (5) LV epicardium.  B: Example traces of recorded electrical activity. C: 
Single example traces indicating the peaks where recordings were measured. D:  
Representative trace from one heart showing the changes in activation times during cooling  
 
The mean changes in electrical activity during cooling to 31°C (Figure 5.8A) 
showed no difference in activation times from stimulus to either atrial or 
ventricular points when compared to 37°C. During cooling to 17°C, all times 
were significantly slowed compared to baseline and 31°C. In particular, time 
from stimulus to atrial activation was more than 4 times longer at 462% of 
baseline (76.9 ± 4.5 vs. 17.5 ± 1.2 ms, p<0.01), compared to activation of the 
ventricles which was ~280% of baseline (p<0.001). Upon rewarming to 31°C there 
was no difference between atrial or ventricular activation times, and at 37°C all 
values returned to baseline. 
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Figure 5.8: Changes in regional electrical activity compared to normothermic baseline. 
A: Percentage change at individual areas of heart. B: Differences between regions.  
*Significant difference between temperatures. # Significant difference within temperature. 
 
To investigate whether there were temperature dependent effects within 
specific pathways of the heart, differences between regions were examined 
(Figure 5.8B). At 37°C, all pathways showed similar timings, but when hearts 
were cooled to 17°C, all paths were significantly slower when compared to 
baseline (p<0.001). In particular, endo-epi delay was 375% greater than control 
whilst V-epi was 355% of baseline; both of these delays were prolonged more 
than A-V (232%), A-epi (253%) and A-endo (243%) delays (p<0.01). Upon 
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rewarming to 31°C, there were no differences between groups; at 37°C endo-epi 
times did not completely return to baseline values (119%) in contrast to all paths 
involving atrial conduction which were fully reversed. 
 
Figure 5.9 Conduction velocity measurements in atria and ventricle during cooling and 
rewarming. 
A: Absolute CV values in right atria and left ventricle recorded by contact electrodes. B: 
Percentage change in CV in atria and ventricle.  One-way ANOVA (p<0.01) shows differences 
between temperature but no difference between atria and ventricle. 
 
Atrial vs ventricular conduction during hypothermia and rewarming 
These findings, combined with the ECG data showing differences in PR and QT 
intervals raised the question of whether there were temperature-dependent 
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effects between the atria and the ventricle. CV was measured using contact 
electrodes placed on the right atria (RA) and left ventricle (LV) in a subset group 
(n=4).  Figure 5.9 shows that cooling to 31°C slowed RA conduction to 85% (51.5 
± 8.2 vs 44.5 ± 7.9 cm/sec) and LV to 82% (44.8 ± 2.1 vs 36.8 ± 1.8 cm/sec) 
compared to baseline. At 17°C RA conduction was further reduced to 52% and LV 
to 46% of baseline.  Rewarming returned values to baseline.  Statistical analysis 
showed that there were differences within the group (p<0.001) however these 
differences were only between temperature, with no difference in conduction 
between atria and ventricle.  
 
VF threshold  
Taken together these results indicated that hypothermic temperatures had 
effects on whole heart conduction.  However, the arrhythmogenic risk that 
accompanied these changes in ECG and conduction at 31°C and 17°C was 
unclear. Therefore, we examined the effect of temperature on VF threshold as 
an indicator of arrhythmia. At 37°C, VF threshold was 30.5 ± 6.8 mA (Figure 
5.10).  Cooling hearts to 31°C decreased VF threshold compared to 37°C (30.5 ± 
6.8 mA vs 14.0 ± 2.2 mA, p<0.05) indicating a more pro-arrhythmic state. In all 
but one heart VF threshold decreased at 31°C (n=7).  However, further cooling 
to 17°C increased VF threshold (64.2 ± 9.9 mA, p<0.05) to a value higher than 
that seen at 37°C. During rewarming to 31°C and subsequently to 37°C, a 
reversed sequence of VF threshold changes was observed. 
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Figure 5.10 VF threshold during cooling and rewarming.  
A: Mean VF threshold at all temperatures.  B: Individual values from each heart (dashed 
lines) showing cooling to 31˚C (n=7) and to (C) 17˚C (n=6).  Solid line shows mean values.   
*Significant difference between temperatures (p<0.05). 
 
Whole heart action potential characteristics 
Measurements of epicardial optical action potentials revealed changes in 
activation and repolarisation times (Figure 5.11). Data associated with 
ventricular activation (TAct90 and Trise) showed no significant changes at 31°C 
while repolarisation characteristics (TRepol90 and APD90) were prolonged by 
124% (305.2 ± 6.3 ms vs. 380.2 ± 8.4 ms, p<0.05) and 136% (176.92 ± 4.2 ms vs. 
241.0 ± 2.9 ms, p<0.05) respectively. Compared to baseline both APD90 and 
TAct90 were prolonged to the same degree when hearts were cooled to 17°C. 
APD90 showed a 242% prolongation (135.5 ± 6.6 vs 333.2 ± 7.8 ms, p<0.05) and 
TAct90 was prolonged by 246% (176.9 ± 4.2 vs 428.2 ± 29.2 ms, p<0.05). During 
rewarming to 31°C, Tact90 returned to baseline levels while APD90 was 
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prolonged compared to control (176.9 ± 4.2 vs 263.0 ± 5.2 ms, p<0.05). During 
rewarming to 37°C all parameters returned to baseline levels. Normothermic 
control hearts showed no significant differences in any of these parameters over 
the same period).  
 
 
 
Figure 5.11 : Activation and repolarisation characteristics during cooling and rewarming. 
Compared to normothermic baseline. Optical mapping of hearts to show (A) Time to 90% 
Activation (Tact90) and (B) Action Potential Duration at 90% repolarisation (APD90) is 
displayed alongside percentage values relative to pre-hypothermic baseline (C). *Significant 
difference between temperatures. # Significant difference within temperature.  
 
CV measured by panoramic optical mapping 
Epicardial CV over a large area of the ventricle was measured in the same hearts 
with epicardial pacing on the RV/LV border and analysing the subsequent spread 
of activation in the longitudinal axis. CV was reduced to 66% of baseline during 
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cooling to 31°C (52.8 ± 7.3 vs 35.2 ± 3.7 cm/sec, p<0.05). After cooling to 17°C 
a reduction to 37% of baseline was observed (19.7±3.7 cm/sec, p<0.05). When 
rewarmed to 31°C, CV returned to values similar to that seen on initial cooling 
(36.9±5.7 cm/sec). Upon rewarming to 37°C, CV values returned to within 
baseline values. 
 
 
 
Figure 5.12 Total cardiac vs epicardial CV  
Total cardiac (RA pacing) vs epicardial CV (RV pacing). *Significant difference between 
temperatures. # Significant difference within temperature. 
 
Longitudinal vs transverse conduction 
Further examination of CV explored the differences between CVl and CVt 
throughout cooling and rewarming (Figure 5.13). In experiments using contact 
electrodes, cooling to 31°C decreased CV in the longitudinal axis by 32% (76.3 ± 
11.9 vs. 51.8 ± 10.1 cm/sec) and by only 13.5% in the transverse (22.6 ± 1.4 vs 
19.5 ± 1.2 cm/sec). At 17°C, CVl decreased by 73.2% (76.3 ± 11.9 vs 20.7 ± 4.2 
cm/sec) and CVt decreased by 52.3% (22.6 ± 1.4 vs 10.5 ± 0.9 cm/sec) (p<0.01). 
Rewarming to 31°C increased both CVl and CVt and achieved values that were 
similar to that seen on initial cooling. After rewarming to 37°C, CV values were 
not different from pre-cooling values. 
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Figure 5.13 Longitudinal vs transverse CV during cooling and rewarming.   
A: Example traces showing longitudinal (black) and transverse (red) conduction time. B: 
Absolute CV values through cooling and rewarming. C: Percentage change CV. Significant 
differences between longitudinal and transverse at same temperature. *p<0.05. **p<0.01 
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Discussion 
The present results show that cooling to 31°C does not significantly change 
ventricular activation, but creates repolarisation abnormalities and is pro-
arrhythmic. Cooling to 17°C causes parallel changes in ventricular activation and 
repolarisation and these changes are not pro-arrhythmic. Non-linear effects on 
ventricular activation can be explained in terms of a low temperature sensitivity 
of gap junction function. These hypothermia-induced changes in cardiac 
electrophysiology are observed at temperatures relevant for diverse clinical 
settings.  
 
Moderate hypothermia (≤34°C) has been used therapeutically as a neuro-
protectant, particularly in survivors of cardiac arrest (Callaway et al., 2015; 
Scirica, 2013) although recent meta-analyses have not shown a benefit in terms 
of survival or neurological outcome (Yu et al., 2015; Huang et al., 2015; Zhang 
et al., 2015) meaning that routine use of therapeutic hypothermia in cardiac 
arrest survivors is unlikely to continue. Severe (<30°C) hypothermia is a more 
extreme situation, yet survival is possible at such temperatures, with 13.7°C 
being the lowest recorded temperature reported in a patient recovering from 
accidental hypothermia with a good neurological outcome (Gilbert et al., 2000). 
The great reduction in metabolic demands induced by severe hypothermia is also 
utilised for neuroprotection during various surgical procedures (Di Luozzo and 
Griepp, 2012; Dietrichs and Dietrichs, 2015). Nevertheless, treatment of 
hypothermia-induced arrhythmias remains challenging (Vanden Hoek et al., 
2010) and knowledge of underlying mechanisms is of high clinical value.  
 
Hypothermia and conduction through the heart 
Electrical and whole heart conduction timings in the present study indicated 
differential effects of conduction through the myocardium in moderate and 
severe hypothermia. At 31°C, only a mild relative delay in atrial and AV nodal 
conduction was present, while at 17°C conduction was significantly slower 
(Figure 5.7D, 5.8A). This is consistent with findings in humans, where AV nodal 
conduction is slowed by direct cooling of the AV node by cold (4°C) isotonic 
saline (Gould and Reddy, 1976). Similarly, in vivo findings have shown that 
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18.3°C is a critical temperature for the occurrence of AV-block in hypothermia 
(Hamilton et al., 1936). In contrast, evident from ECG (QR-time) and whole 
heart conduction timing data, transmural (transverse) ventricular conduction 
appears relatively insensitive to cooling at 31°C.  
 
Panoramic optical mapping of hearts during cooling confirmed conduction 
timings from the ECG as well as electrode-based measurements, and showed 
unchanged ventricular activation (TAct90, TRise) compared to 37°C. Although 
ventricular transverse conduction and activation parameters appear insensitive 
to moderate hypothermic conditions, the timings related to repolarisation 
(APD90 and TRepol90) show pronounced effects at 31°C that are further 
enhanced at 17°C (Figure 5.11). Therefore, in moderate hypothermia, there is 
slowing of conduction through the heart, mostly in the atria and AV node whilst 
ventricular/transmural activation remain relatively unaffected. However, 
ventricular repolarisation is significantly prolonged in the presence of unchanged 
activation, producing a form of acquired long-QT syndrome. Indeed, in the 
clinical setting, long QT syndrome is a common finding in TH (Kim et al., 2014) 
although the clinical relevance of this finding is unclear likely due to the 
confounding influence of pre-existing QT-prolongation, electrolyte derangement 
and use of anti-arrhythmic drugs in the comatose survivors of VT/VF cardiac 
arrests. In one meta-analysis, the use of TH was associated with an increased 
risk of recurrent arrest (Huang et al., 2015) possibly due to QTc prolongation and 
pro-arrhythmia in these patients. Further cooling to 17°C induces a global 
activation delay, including a significant delay in transverse ventricular 
activation, reducing the global activation and repolarisation differences. 
 
Ventricular fibrillation threshold during hypothermia 
Whole heart conduction timings showed a markedly greater effect as 
temperature was lowered from moderate to severe hypothermia.  VF threshold 
showed a different pattern of changes during hypothermia:  cooling to 31°C 
showed a significant reduction in VF threshold (pro-arrhythmic), while further 
cooling to 17°C showed a substantial increase in VF threshold (anti-arrhythmic) 
to more than twice that measured at 37°C.  
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This finding implies that electrophysiological changes within the heart at 31°C 
provide a more stable substrate for arrhythmias than at 17°C. Indeed, it has 
been shown in another study of isolated Langendorff perfused rabbit hearts that 
cooling to 30°C increased the vulnerability of the heart to VF (Hsieh et al., 
2009). These findings are in line with results from an in vivo study of dogs, 
progressively cooled from 37°C to 25°C, (Mortensen et al., 1993) which reported 
that cooling from 31°C to 25°C caused a significant lowering of the number of 
extra stimuli required to induce VF. The current study is the first to demonstrate 
experimentally the biphasic relationship in excitability of the ventricle, 
suggesting that moderate hypothermia (31°C) may make the heart more 
vulnerable to induction of arrhythmias than deep hypothermia (17°C). 
Therapeutically, temperatures <28-30°C are thought to potentiate the 
occurrence of ventricular arrhythmias. Yet 30°C is the lower end of 
temperatures reported to be used following cardiac arrest in the comatose 
patient (Polderman and Herold, 2009). 
 
Although we found pro-arrhythmic changes at 31°C, the opposite was the case at 
17°C, at which temperature a more stable electrophysiology was observed. The 
reasons for the difference in VF threshold between moderate and severe 
hypothermia remain unclear. Based on our data, it is possible that the observed 
biphasic response to cooling could be linked to the absence of significant effects 
on ventricular activation times at 31°C while repolarisation values are 
prolonged, contrasting with 17°C where activation times are substantially 
prolonged in parallel with repolarisation values. The QR-time of the QRS 
complex represents ventricular conduction from endocardium to epicardium and 
is used as a marker of ventricular activation (Perez-Riera et al., 2016). Because 
this transmural conduction is mainly in the short (i.e. transverse) axis, the 
question of whether CVt and CVl are altered differentially in hypothermia 
merited further study. 
 
CVl vs CVt in hypothermia 
Separate measurements of CV (Figure 5.13) show that moderate hypothermia 
affected longitudinal and transverse conduction differently. Although CVl 
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decreases consistently throughout cooling, CVt was relatively insensitive to 
cooling to 31°C, but decreased on cooling further to 17°C. CV is determined by 
multiple factors, including tissue excitability and intercellular resistance; the 
former is linked to inward Na+ current amplitude, and the latter determined by 
connexin-mediated gap junctions. For equivalent distances, gap junction 
resistance has a greater contribution to transverse conduction velocity (CVt) 
whilst Na+ channels and intracellular resistance has a greater involvement in 
longitudinal conduction (CVl). This differential response between CVt and CVl at 
moderate hypothermia may suggest that moderate hypothermia has only a small 
effect on gap-junction resistance relative to the effect on Na+ current. To 
explore the role of the two major determinants of CV, propagation along a 
myocardial fibre of fixed length, measuring activation time at the unstimulated 
end was modelled computationally (Figure 5.14). This model showed that 
reducing gap junctional conductance by a quarter (e.g. from 2 to 0.5 µS) caused 
a 50% reduction in CVt but only an 11% reduction in CVl (Figure 5.14B). In 
contrast, reducing intracellular conductance to 25% of control (Figure 5.14C) 
reduced CVl by 34% whereas CVt is only reduced by 5%. This modelling suggests a 
hypothesis to explain the asymmetric changes in CVl and CVt seen in 
hypothermia, namely that the intracellular resistance (e.g. Na+ current) is more 
sensitive to reduced temperature than gap-junction resistance. Thus, in 
moderate hypothermia CVt, which is dominated by gap-junction resistance, was 
little affected while CVl, which is determined by inward Na+ current, was 
reduced by 32%. 
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Figure 5.14: Computational modelling of longitudinal and transverse conduction.  
A: Schematic representation of an idealised cuboid cell of length lcell, width dcell, showing 
resistance to current flow along and transverse to the cell’s length where Rcl is the 
cytoplasmic resistance along the cell, Rct is the cytoplasmic resistance transverse to the cell 
and Rj is the resistance of the gap junction. B: Variation in CV as gap junction conductivity is 
varied and (C) variation in CV as intracellular conductivity is varied. 
 
 
Mechanisms of arrhythmias in hypothermia 
These results have shown that at 31°C there was a prolongation of ventricular 
repolarisation with minimal change in timing and pattern of ventricular 
activation. This is accompanied by lower VF threshold at 31°C, which is not seen 
at 37°C or 17°C. It is known that ventricular arrhythmias can arise from 
disruptions in the normal sequence of activation and repolarisation (Weiss et al., 
2010). The primary change in ventricular electrophysiology at 31°C is 
prolongation of the APD and increased heterogeneity of ventricular 
repolarisation, both of which are considered pro-arrhythmic changes. 
Interestingly, at 17°C these changes are more pronounced, but the 
accompanying decrease in transverse CV appears to raise VF threshold.  
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Conclusion 
This study suggests that prolonged and heterogeneous repolarisation is only pro-
arrhythmic in the context of normal activation times, suggesting that slowing CV 
and consequently prolonging activation time should be anti-arrhythmic. 
 
Limitations 
All work was carried out on isolated rabbit hearts which were therefore not 
under normal autonomic modulation that is present in vivo. In addition, the 
recordings were limited to 3 set points so as to allow the heart to physiologically 
stabilise at each temperature. In future work it would be useful to be able to 
record electrophysiology during cooling in order to identify the temperature in 
which hypothermia becomes anti-arrhythmic. 
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Chapter 6:  The effect of gap junction 
uncoupling on cardiac conduction during 
hypothermia 
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Introduction 
The findings from the previous chapter showed that there were differential 
effects on cardiac conduction when cooling to 31°C.  The primary change in 
ventricular electrophysiology at 31°C was prolongation of the APD and increased 
heterogeneity of ventricular repolarisation, both of which are considered pro-
arrhythmic. At 17°C these changes were more pronounced, but the 
accompanying decrease in transverse CV appeared to raise VF threshold. This 
suggests that prolonged and heterogeneous repolarisation is only pro-arrhythmic 
in the context of normal activation times, suggesting that slowing CV and 
consequently prolonging activation time in proportion to the other 
electrophysiological changes should be anti-arrhythmic.   
 
Intercellular coupling 
Under normal circumstances, the heartbeat is initiated in the sinoatrial (SA) 
node, conducted across the atria, delayed at the AV node, after which the 
ventricular myocardium is activated via the specialised conduction system. For 
the heart to function it is essential that there is a rapid conduction of this 
cardiac impulse, requiring the presence of low resistance connections between 
cardiac cells (Rohr, 2004). The speed is dictated by the action potential shape, 
particularly the leading phase, and the electrical properties of the cell, where 
the conductance of the electrical cable is inversely related to the intercellular 
(internal) resistance. Low resistance favours fast conduction and the gap 
junction channels provide low resistance connections between cardiac cells 
(Spach, 1999).  Propagation occurs rapidly through the cytoplasm and slows at 
the intercellular junctions, so conduction is discontinuous.  Due to the 
arrangement of myocardial fibres, conduction from endo to epicardium is at a 
direction transverse to the fibre axis. The speed of propagation in this direction 
is less than half that in the longitudinal axis (Roberts et al., 1979; Valderrabano, 
2007). This is thought to be due to the greater number of gap junctions (per unit 
length) in the transverse direction (Figure 6.1) (Campbell et al., 2014).  
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Figure 6.1: Organisation of cardiomyocytes and gap junctions. 
Schematic showing the organisation of cardiomyocytes and their communication via the 
intercalated disc. Fewer gap junctions (part of intercalated disc) in longitudinal direction vs 
transverse. Diagram adapted from: (Campbell et al., 2014). In longitudinal propagation the 
impulse travels through less junctions per unit space than in transverse propagation, 
therefore the former experiences less delays than the latter. 
 
Gap junction uncoupling 
Under normal circumstances the heart acts as an electrical syncytium via gap 
junctions. However, if gap junction coupling or gap junctional resistance are 
altered then an increased heterogeneity of repolarisation can occur, and this 
exaggerated dispersion may be arrhythmogenic.  This cellular uncoupling has 
been demonstrated in the various forms of injury and in the later phases of 
ischaemia (Kanno and Saffitz, 2001; Severs et al., 2008; Tse and Yeo, 2015). As 
cells become progressively uncoupled (gap junctional resistance increases and 
gap junctional conductance decreases), conduction velocity decreases 
monotonically (Shaw and Rudy, 1997). This reduction in conduction velocity is 
due to longer delays in propagation across the gap junctions. 
 
 
Heptanol 
Gap junctions can be uncoupled pharmacologically using various different 
agents. For the benefit of this study, two separate gap junction uncouplers were 
selected. Firstly, the lipophilic agent heptanol.  There are several theories 
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proposed for the mechanism of action, however the most common explanation is 
that the drug is incorporated into the lipid bilayer which in turn leads to 
impairment of the gap junction channels. It has been reported that heptanol 
reduces coupling by reducing the open probability of the gap junction channels. 
Heptanol has been used to study the effect of gap junction uncoupling and 
slowed conduction in both the intact heart (Keevil et al., 2000; Tse and Yeo, 
2015) and in paired cardiomyocytes (Rüdisüli and Weingart, 1989; Takens-Kwak 
et al., 1992).  
 
Carbenoxolone 
Carbenoxolone (CBX) is a mineralocorticoid that is used to promote healing in 
the treatment of gastric and mouth ulcers. It is thought to work by stimulating 
the production of mucus that forms a protective coating over the stomachs 
lining. Initially, experimental work with carbenoxolone was restricted to 
neurological investigations where it was found to reversibly abolish gap junction 
mediated intercellular coupling, however in recent years there have been more 
studies examining the cardiac effect. One study by deGroot (2003) concluded 
that carbenoxolone was an effective agent that delayed conduction and caused 
localised conduction slowing which indicated gap junction uncoupling. They also 
reported no adverse effects on action potential characteristics, whilst calcium, 
sodium and potassium currents remained unaffected. In a separate study it has 
also been shown in humans to reduce wavefront propagation by 27% whilst not 
affecting refractoriness (Kojodjojo et al., 2006). The slowing of myocardial 
conduction by carbenoxolone in this study demonstrated that it is a useful agent 
for investigating the effects of gap junction uncoupling on human 
arrhythmogenesis. 
 
Aims 
In the previous chapter slowing of conduction was associated with a pro-
arrhythmic state at 31˚C but not at 17˚C. The temperature sensitivity of the gap 
junction was a proposed mechanism which could be modulated. Therefore, the 
aims of this chapter were: 
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i) to assess the effect of pharmacological gap junction uncoupling on CVl and CVt 
during moderate hypothermia. 
ii) to examine whether any alterations in CV had a subsequent effect on VF 
threshold. 
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Methods 
Male New Zealand White Rabbits (~3-3.5kg) were used for all experimental work 
in this chapter.  Hearts were isolated and Langendorff perfused (as described in 
Chapter 2). All hearts were perfused with Blebbistatin (10µM) and allowed a 
settling period of approx. 20 mins to physiologically stabilise before any 
recordings were made. CVl, CVt and VF threshold was recorded (see Chapter 5 
for full description) at 37°C, 31°C and following pharmacological gap junction 
uncoupling.  
  
Gap junction uncoupling with CBX 
Previous work in our lab studied a concentration range of 10-100 µM (CBX) on 
whole heart electrophysiology.  It was found that <50 µM had little effect on 
electrophysiology, however >60 µM had dramatic and toxic effects on the heart, 
including an increase in perfusion pressure as well as an increase in end systolic 
and end diastolic pressures. Based on these findings, concentrations of 3 µM, 10 
µM and 50 µM were used for this study. CBX (Sigma, UK) was dissolved in de-
ionised water and was prepared immediately prior to each experiment.  
Following CV and VF threshold measurements at 31°C hearts were allowed 
approx. 15 min recovery time. CBX (3 µM) was delivered to the heart over a 5 
min period via syringe driver (Figure 6.2). Following recordings, the heart was 
allowed a 25 min washout period with Tyrode’s solution (de Groot et al., 2003) 
before increasing CBX concentration to 10 µM.  The process was repeated for 50 
µM. 
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Figure 6.2: Diagram of syringe driver. 
Diagram showing the setup of syringe driver used to deliver CBX to the heart.  Perfusion was 
maintained at a constant rate, to ensure concentration remained the same throughout.  A 
syringe cannula was used to allow the CBX to be delivered as close to the coronary arteries 
as possible and minimise ‘dead space’ in the system. CBX was perfused at 0.4ml per min and 
mixed with Tyrode’s solution (31°C) before reaching the aorta. 
 
Gap junction uncoupling with heptanol 
Separate experiments pharmacologically inhibited gap junctions using heptanol 
(0.3mM). This concentration was based on previous work within our lab which 
showed significant effects on CV in isolated rabbit hearts. Due to the lipophilic 
nature of heptanol it is insoluble in water so it was dissolved in ethanol before 
adding to Tyrode’s solution. The final concentration of ethanol in the solution 
was less than 0.005%.   
Following CV and VF threshold measurements at 31°C, the heart was allowed 
approx. 15 min to recover following which perfusion was changed to heptanol via 
a 2-way switch incorporated in the perfusion lines.  After 5 min perfusion CV and 
VF threshold measurements were taken. Due to the reversible nature of 
heptanol (Takens-Kwak et al., 1992), perfusion was continued until CV and VF 
measurements were complete. 
 
Statistical analysis 
Data are expressed as mean ± SEM. CV and VF threshold measurements were 
assessed by one-way ANOVA for repeated measures. When significant differences 
were found, data were post-hoc analysed using Tukey’s test. All statistical tests 
were performed using GraphPad Prism software. 
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Results 
Effect of CBX during moderate hypothermia 
In this study, initial experiments (n=2) were carried out to examine the response 
of CV with different concentrations of the gap junction uncoupler CBX. Hearts 
were perfused with 3µM, 10µM and 50µM CBX at 31°C, with a washout period of 
25 mins between each concentration.  For these initial experiments, continuous 
CVt recording was carried out to assess the response of the drug.  Due to 
limitations with equipment, both CVl and CVt could not be recorded 
simultaneously. Cooling to 31°C reduced CVt by 12.6% compared to 37°C.  
However, the addition of CBX at 3µM showed a reduction in CVt of only 10.9 % 
compared to baseline.  In comparison to this, 10µM and 50µM CBX decreased CVt 
by 16.5% and 24.5% respectively.  Based on these findings, further experiments 
(n=4) were carried out using only 10µM and 50µM CBX. 
 
The effect of CBX perfusion on CV and VF threshold can be seen in Figure 6.3.  
Example traces show that both 10 µM and 50 µM slowed conduction. The 
difference between CVl and CVt when cooling to 31°C can be clearly seen in 
Figure 6.3B, where there appears to be a greater effect on CVl than CVt. 
Moderate hypothermia decreased CVl by 29.9 ± 6.2% compared to 37°C (p<0.05).   
The addition of 10 µM CBX decreased CVl by 36.3 ± 9.8 % (p<0.05) and by 52.9 ± 
10.8% at 50 µM (p<0.01).  Conduction in the transverse axis (Figure 6.3 A-C) was 
reduced by 17.9 ± 1.8% at 31°C when compared to 37°C (p<0.05).  Further 
decreases in CVt of 22.6 ± 4.8% (p<0.05) and 37.4 ± 7.5% (p<0.01) compared to 
baseline (37°C ) were seen at 10µM and 50µM respectively.   
Figure 6.3D shows VF threshold measurements in the presence of CBX. Cooling to 
31°C significantly decreased VF threshold (38.8 ± 8.5 vs 16.9 ± 3.9 mA, p<0.05).   
The addition of 10µM and 50µM CBX further decreased VF threshold to 16.4 ± 4.6 
mA (p<0.05) and 8.6 ±2.1 mA (p<0.01) respectively.  At both 10 µM and 50 µM all 
hearts required cardioversion using KCl to return to sinus rhythm following VF.   
These findings indicate that gap junction uncoupling by CBX had a greater effect 
on CVl than CVt at 31°C.  This was accompanied by a reduction in VF threshold 
suggesting that CBX is pro-arrhythmic in hypothermic conditions.  
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Figure 6.3: Effect of CBX on CV and VF threshold 
A: Example traces of CV (transverse) at 31°C (black) and following perfusion of 10µM (blue) 
and 50µM (green) CBX.  B: Mean longitudinal (black circles) and transverse (grey circles) CV 
values following hypothermia and CBX perfusion.  C: Percentage change of CV.    D: VF 
threshold measurements.  *p<0.05, **p<0.01 
 
Effect of heptanol during moderate hypothermia 
Separate experiments (n=4) examined CV and VF threshold following 5 mins of 
0.3mM heptanol perfusion.  Figure 6.4 shows the effect of heptanol on CV and VF 
threshold.  Cooling to 31°C slowed CVl by 35.5 ± 3.6 %, whilst heptanol reduced 
it by 44.3 ± 2.5% when compared to 37°C (p<0.01).  CVt was reduced by 14.5 ± 
1.2% at 31°C (p<0.05) and 28.1 ± 1.9% following heptanol (p<0.01), when 
compared to 37°C baseline. There was a significant difference of 13.6% between 
CVt at 31°C and following perfusion with heptanol.   
Figure 6.4D shows VF threshold measurements in the presence of heptanol. 
Cooling to 31°C significantly decreased VF threshold (35.0 ± 3.5 vs 16.3 ± 3.1 
mA, p<0.05).  Following perfusion with heptanol during hypothermia VF 
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threshold increased back to baseline values. In 3 out of 4 experiments hearts 
converted to sinus rhythm spontaneously without the need for KCl. 
 
Figure 6.4: Effect of heptanol on CV and VF threshold 
A: Example traces of CV (transverse) at 31°C (red) and following perfusion of 0.3mM (blue) 
heptanol. B: Mean transverse conduction at 31°C and throughout 5 mins of heptanol 
perfusion. C: Percentage change of CV.  Shown are the differences between 31°C and 0.3mM 
heptanol. D: VF threshold measurements.   *p<0.05, **p<0.01 
 
Gap junction uncoupling and anisotropy 
Figure 6.5 shows absolute CV values following hypothermia and gap junction 
uncoupling alongside anisotropic ratio (CVl/CVt).  Ratio was calculated between 
37°C and 31°C and between 31°C and pharmacological intervention. No change 
in anisotropy was detected between hypothermic hearts and following CBX at 
either 10µM or 50 µM.  In contrast to this, the addition of heptanol showed a 
strong trend towards an increase in ratio (p=0.07). 
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Figure 6.5: Gap junction uncoupling and anisotropy. 
A: Left panel shows absolute CV values.  Black and red lines represent CVl and CVt following 
CBX, whilst grey and blue lines represent the addition of heptanol. Left panel shows 
anisotropic ratio (CVl/CVt).  Light grey bars show ratio between 37°C and 31°C.  Dark 
grey/black represent ratio between 31°C and addition of CBX/heptanol.  
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Discussion 
Following on from the results of Chapter 5, this study described the effect of gap 
junction uncoupling at 31˚C alongside parallel measurements of VF threshold. To 
test the hypothesis that maintained CVt when cooling from 37°C to 31°C is 
required for a pro-arrhythmic state induced by cooling to 31°C, VF threshold was 
examined at moderate hypothermia (31°C) before and after CVt was reduced 
pharmacologically. As anticipated from the computational model, heptanol, a 
gap junction uncoupler, lowered CVt proportionally more than CVl and when 
heptanol was applied to hearts at 31°C it increased VF threshold to within 
normothermic values. The dose of heptanol used reduced the relative CVt to the 
same extent as the hypothermia-induced delays in other parameters of cardiac 
conduction. The use of CBX as a gap junction uncoupler did not show the same 
effects and led to increased arrhythmias. There are several findings from this 
work that are important to mention: 
 
i. The slowing of conduction at 31˚C supports evidence that reducing 
temperature decreases gap junctional conductance (Bukauskas and 
Weingart, 1993; Chen and DeHaan, 1993).  
 
ii. Gap junctional uncoupling by CBX showed a greater effect on CVl than CVt 
which was accompanied by a significant reduction in VF threshold.  The 
reason for the difference in CVl and CVt is not clear as previous reports 
have shown that infusion resulted in decreased transverse but not 
longitudinal CV. However there are several reports about the non-
specificity of CBX in neuronal gap junctions (Connors, 2012) and side 
effects as a result of electrolyte imbalances (Davies et al., 1974). In 
cardiac preparations it has been shown to reduce gap junction 
permeability, however it has been associated with either no change in VF 
threshold or an increased incidence of arrhythmias (de Groot et al., 2003; 
Miura et al., 2016). 
 
iii. Gap junctional uncoupling by heptanol showed a greater effect on CVt 
than CVl.  The efficacy of heptanol as a gap junction uncoupler is well 
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described (Delmar et al., 1987; Balke et al., 1988; Rüdisüli and Weingart, 
1989; Takens-Kwak et al., 1992;Keevil et al., 2000;  Tse et al., 2016). 
However there have been differing reports on the effect of heptanol and 
the incidence of arrhythmias.  Evidence has suggested that regional 
perfusion with heptanol may decrease CV but could also induce atrial 
(Ohara et al., 2002) and ventricular (Tse et al., 2016) arrhythmias. In 
contrast to this, and in line with our findings, Sun (2014) showed that 
there was a decreased incidence of VF after heptanol infusion. 
 
Gap junction uncoupling and the subsequent slowing of conduction (particularly 
in the transverse direction) abolished the pro-arrhythmic state that was induced 
by moderate hypothermia. One possible explanation for this finding is the safety 
factor principle of conduction. Shaw and Rudy (1997) described the safety factor 
as a dimensionless parameter that indicates the margin of safety with which the 
action potential propagates relative to the minimum requirements for sustained 
conduction. When an action potential propagates, the excited cell serves as a 
source of electric charge for neighbouring unexcited cells towards their 
excitation threshold.  For propagation to succeed, the excited cell must provide 
sufficient charge to the unexcited cells to bring their membrane to excitation 
threshold. Once the threshold is reached and the action potential is generated, 
the load on the excited cell is removed and the newly excited cell becomes the 
source for downstream tissue, which in turn perpetuates the action potential 
propagation. This has been described as a source-sink relationship whereby the 
source is the electric charge and the sink is the unexcited cell. (Kléber and 
Rudy, 2004).  
 
There will be a lowered safety factor for conduction when there is reduced 
excitability. This means that the propagating action potential can slow or stop, 
leading to conduction block or re-entry. As well as reduced membrane 
excitability, gap junction uncoupling also decreases the velocity of the 
propagating action potential. Both theoretical (Joyner, 1982; Rudy and Quan, 
1987) and experimental (Spach et al., 1981; de Bakker et al., 1988; Delgado et 
al., 1990) studies have suggested that there is a greater slowing through gap 
junction uncoupling compared to reductions in excitability.  Despite the slowed 
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conduction, evidence suggests that propagation across cells with reduced 
coupling has a high safety factor (Leon and Roberge, 1991; Rohr, 2004). 
 
Based on this model, moderate hypothermia (31ºC) produces an environment 
where there is a low safety factor, and as a result there is an increased risk of 
arrhythmia. However, the use of heptanol to uncouple gap junctions and further 
slow CVt provides a more stabilised cellular environment whereby the action 
potential is able to fully propagate. This suggests that the relative difference in 
CVl and CVt in moderate hypothermia is an important aspect of the safety factor. 
  
Conclusions 
These findings propose that the low temperature sensitivity of gap-junction 
conductance is an important pro-arrhythmic factor during moderate 
hypothermia. This suggests that modulation of gap junction function is a 
potential therapeutic target to protect patients in moderate hypothermia from 
arrhythmias during therapeutic as well as during accidental hypothermia. 
 
Limitations 
The limitations described here also apply to chapter 5. There seemed to be 
variation between baseline CV values in different hearts, ranging from ~65-
90cm/sec in the longitudinal direction. This is likely due to the differences in 
position of the electrode on each heart. Although every effort was made to keep 
the angle consistent, every heart has a different fibre architecture. The 
different effects of CBX and heptanol was also limiting and it would be useful if 
there was a specific gap junction blocker that could be applied to both research 
and clinical practice. 
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Chapter 7: General Discussion 
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The general aims of this thesis were to assess cardiac electrophysiology and 
mechanical function at temperatures occurring in therapeutic and accidental 
hypothermia. 
 
Inotropic response to hypothermia 
This work aimed to better understand hypothermia/rewarming induced 
contractile dysfunction. The first aim was to address whether the inotropic 
response following hypothermia and rewarming that is evident in vivo could be 
recapitulated in an in vitro model. The findings showed that following 3 hours at 
16˚C (stimulated at 1Hz), upon rewarming there was a greater than 50% 
reduction in shortening. These findings were similar to a recently published 
study using a similar cell model by Schaible et al  (2016). This was not 
accompanied by a change in cytosolic Ca2+ transients therefore suggesting a 
lowered myofilament response to Ca2+ was the basis of the reduced inotropy. 
Several mechanisms were proposed to explain this change in sensitivity 
including; metabolic dysfunction, possibly as a result of increased mitochondrial 
Ca2+ (Wold et al., 2013), cAMP/PKA mediated phosphorylation of cTnI (Han et 
al., 2010), or due to an increase in reactive oxygen species and subsequent 
modification of the myofilaments. Whilst the underlying mechanism of this 
myofilament sensitivity was not identified within this study, it has provided a 
reproducible model of rewarming induced contractile dysfunction in isolated 
myocytes that can be used in future work. 
 
The second aim of this work was to assess electrophysiology in isolated hearts 
following in vivo hypothermia and rewarming. This work showed that 3 hours of 
stable hypothermia followed by rewarming led to a significant reduction in CO 
when compared to baseline. Ventricular epicardial AP measurements showed 
that these hearts also displayed a shorter APD.  This may be as a result of 
metabolic disruptions in the myocyte leading to opening of the KATP channel. 
Assessment of transient hypothermia in separate experiments showed that APD 
was prolonged following rewarming. These findings showed that following in vivo 
hypothermia/rewarming there was a contractile dysfunction alongside a 
chronically shorter APD, suggesting that a sustained electrophysiological effect 
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that would manifest as a shortened QT interval. In contrast to this, a period of 
transient hypothermia had alternative detrimental effects on the cardiac APD 
when compared to prolonged hypothermia, an effect that could predispose to 
the induction of long QT related arrhythmias and ventricular tachycardia. 
 
A better understanding of the mechanisms involved in this 
hypothermia/rewarming contractile dysfunction may indicate therapies to 
address the issue. Future work could utilise the in vitro cell model to look at the 
possible mechanisms for myofilament sensitivity. A more detailed study looking 
to better understand E-C coupling factors could be carried out on myocytes, e.g. 
modulation of adrenoreceptors and PDE function could be assessed in vitro by 
using isoproterenol and selective PKA and PDE inhibitors. This could potentially 
fit well with recent work using the rat model which has examined the effect of 
pharmacological modulation of the PKA pathway  (Dietrichs et al., 2014a; 
Dietrichs et al., 2014b) and has shown promising results, with improvements in 
CO and SV after rewarming.  Future work using the optrode should also look to 
assess whether there it a change in Ca2+ alongside the APD shortening. 
 
Cardiac conduction and hypothermia 
The second part of this thesis focused on the electrical aspects of cooling and 
rewarming. Accidental hypothermia is complicated by risk of ventricular 
arrhythmias, however there is a lack of understanding regarding the underlying 
mechanisms and the optimal treatment of the hypothermic heart. 
 
Chapters 5 and 6 of this thesis focused on cardiac conduction and excitability 
during hypothermia and rewarming. The aim was to assess conduction and 
electrical activity at temperatures seen in therapeutic (31˚C) and also 
accidental hypothermia (17˚C). Findings from this study showed that cooling to 
31˚C prolonged the PR and QT interval, whilst at 17˚C all aspects of the ECG 
were prolonged. Panoramic optical mapping of the LV showed that cooling to 
31°C does not significantly change ventricular activation, but creates 
repolarisation abnormalities (TRepol and APD90 prolongation) and is pro-
arrhythmic. Cooling to 17°C causes parallel changes in ventricular activation and 
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repolarisation and these changes are not pro-arrhythmic. This finding implies 
that electrophysiological changes within the heart at 31°C provide a more stable 
substrate for arrhythmias than at 17°C. The current study is the first to 
demonstrate experimentally the biphasic relationship in excitability of the 
ventricle, suggesting that moderate hypothermia (31°C) may be more vulnerable 
to induction of arrhythmias than deep hypothermia (17°C). Therapeutically, 
temperatures <28-30°C are thought to potentiate the occurrence of ventricular 
arrhythmias. Yet 30°C is the lower end of temperatures reported to be used 
following cardiac arrest in the comatose patient (Polderman and Herold, 2009). 
The experimental work showed that CVl decreased consistently throughout 
cooling, however, CVt was relatively insensitive to cooling to 31°C, but 
decreased on cooling further to 17°C. Therefore, this study suggested that non-
linear effects on ventricular activation can be explained in terms of a low 
temperature sensitivity of gap junction function. To assess this, the effect of 
pharmacological gap junction uncoupling on CVl and CVt during moderate 
hypothermia was studied. Gap junctional uncoupling by CBX showed a greater 
effect on CVl than CVt which was not associated with a change in VF threshold. 
Uncoupling by heptanol showed a greater effect on CVt than CVl and was 
associated with VF threshold that had returned to baseline (37°C). These 
findings propose that the low temperature sensitivity of gap-junction 
conductance is an important pro-arrhythmic factor during moderate 
hypothermia. This suggests that modulation of gap junction function is a 
potential therapeutic target to protect patients in moderate hypothermia from 
arrhythmias during therapeutic as well as during accidental hypothermia. 
 
Future work should examine this finding further. The next step would be to 
identify a clinically relevant inhibitor and test it in vivo, to assess its efficacy as 
a short term treatment of hypothermia. However, identification of that suitable 
drug is as yet unclear. CBX was selected for this work because it is an approved 
drug that is readily available, however it did not show the anti -arrhythmic 
effect of heptanol.  Currently there is work examining the effect of Rotigaptide, 
a novel anti arrhythmic peptide which is being investigated as a potential 
connexin mediated phrarmacological treatment (Su et al., 2015). It has been 
shown to prevent ischaemia-induced ventricular tachycardia (Liu et al., 2014) by 
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altering cell to cell coupling. However further work is required to understand 
whether this is an appropriate choice for the hypothermic heart. 
 
Animal models 
Both rat and rabbit cardiac measurements were examined within these studies. 
This cross species work was due to the different nature of the experimental 
objectives. The studies on the inotropic response of hypothermia were based on 
replicating the rat model of rewarming shock developed by Tveita et al 
(University of Tromso). Therefore, it was logical to develop an in vitro model 
using the same animal. However, for the conduction studies it was more 
practical to use a rabbit model.  The scale of these experiments, and techniques 
used (e.g. conduction timings, panoramic imaging) were designed for a larger 
heart and also the rabbit electrophysiology shares more similarities with the 
human heart (e.g. AP plateau phase is present in rabbits but not small rodents). 
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